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       Section I 
 
            Introduction  
  
 Chronic depression (CD) is a pervasive and unique illness encompassing a subset of five 
disorders and accounting for one-third of all depression cases (Michalak & Lam, 2002; Trivedi 
& Kleiber, 2001).  Depression in general affects 17% of the general population in community 
samples and 25-30% of these patients will develop a chronic depressive course (Pignone, et al., 
2002; Angst, 1997). For the purposes of this paper and project, the term chronic depression 
refers to unipolar, non-psychotic depression (See Appendix A for definitions and Figures 1 
through 5 for graphical depictions) and focuses on adult chronic depression identification and 
treatment challenges. The project was the distillation and synthesis of key information and 
complex evidence-based strategies for the treatment of chronic depression. The material was 
prepared as an educational presentation in the form of a continuing education workshop for 
mental health professionals. The educational component was designed to address the 
aforementioned issues and present synthesized approaches derived from an Evidence-Based 
Psychotherapy (EBP) modality, Cognitive Behavioral Analysis Systems Psychotherapy 
(CBASP) for chronic depression and prepare providers to use the key aspects of the intervention.  
 The research demonstrates that depression in general is a widespread, often under-
recognized and undertreated disorder (Keller, 2003; Pignone, et. al, 2002; Goldman, Nielson, & 
Champion, 1999; Katon & Sullivan, 1990). Further evidence supports that chronic depression 
presents additional clinical and treatment complexity and incurs greater impact and costs. Thus, 
the identification of chronic depression is necessary and significant in terms of accurate 
diagnosis and differentiation from other similar disorders, disease impact and the need for 
application of appropriate treatment. The World Health Organization (WHO) also recently 
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launched an international initiative on depression in public health with the following objectives: 
―To reduce the impact of depression by closing the substantial 'treatment gap' between available 
cost-effective treatments and the large number of people not receiving it, worldwide‖ (2010, 
www.who.int/mental_health/management/depression/definition/en/). Specific WHO aims 
include patient and provider education about depression and to reduce the stigma associated with 
depression. In addition, other goals proposed are the training of primary care personnel in the 
diagnosis and management of depression and regional events to increase awareness of depression 
and, of particular relevance to this project, workshops to strengthen the capacity to care for 
depression (WHO, 2010). 
 This project‘s primary intent was to distill information and synthesize evidence-based 
strategies into an accessible ‗Tool Kit‖ for broad use by community providers working with 
patients with chronic depression. The need to provide these providers with strategies to address 
the issues regarding chronic depression is significant. Consistent with the WHO initiative, the 
intervention or educational component was to provide a day long, interactive continuing 
education (CE) workshop piloted at the University of San Francisco (USF) for mental health 
providers to improve the identification of chronic depression and to learn synthesized evidence-
based tools for the treatment of CD. The project was sponsored by the USF School of Nursing 
and co-sponsored by the School of Education, Department of Counseling Psychology and 
Marriage and Family Therapy. Community, public health, and mental health providers, and in 
particular, nurses, licensed social workers and other clinicians, from California were targeted 
with a minimum goal of 10-12 participants. The workshop was designed for providers to learn 
about chronic depression, to more effectively identify CD and to learn to apply specific strategies 
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developed into a ―Tool Kit‖, and synthesized from an evidence-based psychotherapy (EBP) 
modality, CBASP for CD.  
 Generally, the program addressed the conceptual framework and key elements of CD 
identification and CBASP. The therapeutic goal for clinicians was highlighted: to teach CD 
patients that their behavior has interpersonal consequences or effects (McCullough, 2006, 2001). 
The instruction for the workshop included a variety of learning objectives, tools and modules as 
well as case study vignettes, simulation, and role play with interactive participant exercises to 
solidify learning.  Detailed information folders (See Attached Cox, CE Workshop Packet, 
October 2, 2010) and evaluative tools were disseminated to participants. Pre-assessments 
compiled demographic, education, and professional information and the pre and post-tests also 
queried key educational content areas to assess learning. Evaluations of the offering, and a two 
week follow-up survey regarding content application and barriers to practice were also 
implemented. Evaluations were reviewed to determine necessary content and implementation 
changes for potential future educational events. Treatment challenges and the inefficacy of 
established psychotherapy practices for CD patients, mandate a need for evidence-based 
approaches. CBASP has been shown to be efficacious in several large, rigorous studies and is 
specifically designed to address chronic depression (Keller et. al., 2000; Schatzberg et. al., 2005), 
hence the focus of this project and paper. 
      Clinical Relevance  
 
Depression is a significant, prevalent public health problem and is currently the leading 
cause of disability for adults ages 15-44 in the United States (U. S.) (National Institute of Mental 
Health, NIMH, 2010; Kessler et. al, 2005; Kessler, et. al., 2003). Depression incurs high 
morbidity and mortality rates for individuals. In fact, major depression accounts for 60% of all 
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suicides while all individuals with major mental health problems are estimated to live on average 
25 years less than those who do not suffer from mental illness (Healthcare Intelligence Network, 
HIN, 2009; Kessler, et. al, 2003).  The impact of depression in general is staggering, with annual 
direct and indirect costs estimated at $83 billion in the United States (U. S.) and 11.5 billion 
Euros in the United Kingdom (U. K.) (Espinoza et. al., 2009; Lyness, Schwenk, & Sokol, 2009; 
HIN, 2009). Depression in general accounts for 11% of the international disease burden and is 
the fourth leading cause of disability with growth projections over the next ten years (WHO, 
2010).  In fact, the World Health Organization anticipates that depression will become the 
second leading killer of individuals after heart disease by the year 2020 at the current growth rate 
(WHO, 2010; NIMH, 2010; U.S. Public Health Service (USPHS): Mental Health: A report of the 
Surgeon General).   
Indeed, depression is a worldwide phenomenon and rivals cardiovascular disease (CVD)  
in terms of disability and mortality rates, as well as the public health costs from depression itself 
and the associated co-morbidities (Kneisl & Trigoboff, 2009; Lyness, Schwenk, & Sokol, 2009). 
In particular, costs of all chronic diseases have been found to be higher when an individual 
suffers from a co-morbid depression (See Table I below; Melek & Norris, 2008). Notably, 
morbidity and mortality data show that depression in general is associated with increased risks of 
medical complications and co-morbidity, and specifically death from CVD and stroke, as well as 
suicide (15% of all depressed patients), significant disability including lost work, wages, and 
reduced quality of life (Lyness et. al, 2009; Keller et. al, 1998; Nemeroff et. al., 2003).  
Depression has also been linked to weakened immune system response, cancer, inflammatory 
responses, chronic and autoimmune diseases, implicating perhaps common biologic pathways 
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(Gross, et. al., 2010; Joynt, Whellan & O'Connor, 2003). Thus, depression in general is a 
widespread problem that has a significant impact on individual and public health. 
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Table I 
 
 
Costs of chronic diseases are higher when a co-morbid depression is present. 
 
Depressive Disorder: Higher costs…
 
 
Reference: Melek, S. & Norris, D. (2008, July). Chronic conditions and comorbid psychological 
disorders. Milliman Research Report, 1-20. http://publications.milliman.com/research/health-
rr/pdfs/chronic-conditions-and-comorbid-RR07-01-08.pdf Retrieved June 2010. 
Derived from Cox CE Chronic Depression Workshop October 2
nd
, 2010 slides. 
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Chronic Depression Significance  
Chronic depression, specifically, and its subtypes derive from variations of major 
depression, also referred to as Major Depressive Disorder (MDD) and Major Depressive Episode 
(MDE) (See Table II below for DSM-IV-TR criteria and Figure 6 in appendices for graphical 
depiction). 
       Table II 
The American Psychiatric Association‘s (APA) Diagnostic and Statistical Manual-IV (DSM-IV, 
2000) diagnostic criteria for Major Depressive Disorder (MDD) or Major Depressive Episode 
(MDE): 
 
Quick Review: 
DSM-IV TR Diagnostic Criteria
Major Depression (MDD or MDE)
 At least 5 of the following sxs, present most of the day,
nearly every day (80-90% of time) for at least 2 wks: 
1. Depressed (dysphoric) mood AND/OR,
2. Anhedonia: Loss of interest or pleasure (usual activities) with: 
 Significant weight gain or loss (w/o attempt to ∆ weight, ~5%)
 Insomnia or hypersomnia
 Fatigue or loss of energy
 Psychomotor agitation or retardation
 Feelings of worthlessness, or excessive or inappropriate guilt
 Impaired ability to concentrate, indecisiveness
 Recurrent thoughts of death or suicide (SI)
 May be Single or Recurrent episodes.
 Must represent a change in functioning with Impairment or Marked 
Distress
APA 2000.
 
Derived from Cox, CE Chronic Depression Workshop, October 2
nd
, 2010 slides. 
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 Major depression carries a lifetime risk of 10-25% in the U. S. population with women 
disproportionately affected at a rate of 21.3% compared to 5-12% for men across the lifespan, 
regardless of marital status, income, ethnicity or education (Kessler, et. al, 2005; Kessler, et. al. 
2003; Nemeroff et. al., 2003; American Psychiatric Association, APA, 2000). The impact of 
MDD is growing and as the population increases and ages, the impact of depression and co-
morbid chronic diseases are also rising (Dotson, 2009; Krishnan, et. al, 1993).  Evidence 
supports the premise that 50-85% of patients who have one MDD will experience subsequent 
major depressive episodes and the remission periods in between the depressive episodes become 
shorter over time, suggesting that many of these patients incur a more chronic course later in life. 
A history of previous depressive episodes is, in fact, predictive of future episodes (Niremberg, et. 
al., 2003; DeBattista, 1997).  Co-morbid psychiatric and substance abuse disorders (Kneisl & 
Trigoboff, 2009), further increase the risk for recurrence of depression and a more chronic 
depressive course (Niremberg, et. al., 2003; DeBattista, 1997).  
More specifically, at least half of all first MDE‘s will eventually recur to a second 
episode and of those, 90% recur to a 3
rd
 episode. After three episodes, an individual has a greater 
than 95% chance of suffering another depression in the subsequent two year period (Niremberg, 
et. al., 2003; Keller, 2002). In addition, the greater the number of depressive episodes 
experienced in a lifetime, the shorter the symptom-free or inter-episode periods of recovery 
become, leading ultimately to a greater probability for the development of chronic depressive 
course. Furthermore, evidence further supports that 15-20% of all first MDE‘s initially never 
remit and entail a chronic and unremitting from the onset (Eaton, et. al., 2008; Berlim & Turecki, 
2007; Keller, 2002). Overall, 25-30% of all depressions become chronic, lasting two years or 
longer (Niremberg, et al., 2003; Keller, 2002).  
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Indeed, MDE‘s become more severe, extensive, and refractory over time and with 
subsequent episodes (Niremberg, et. al, 2003; DeBattista, 1997; Thase, 1992). Thus, episodic 
major depressions often recur and progress to a more chronic course and may implicate 
pathophysiologic and neurologic decline (neurodegeneration) with chronicity, wherein the brain 
theoretically ―learns‖ depressive pathways more efficiently and thereby, phenotypically 
expresses dysphoria more easily and frequently (Maes, Yirmyia, Noraberg, et. al., 2009).   
While chronic depression manifests with clinically similar symptoms to episodic and 
recurrent depressive episodes, CD persists unabated for at least two years and can continue for 
much longer. Conservative estimates suggest that 20 million individuals in the U.S. or 10-12% of 
the population suffer from depression in general at any point in time (National Institute of 
Mental Health, NIMH, 2010) according to the original Epidemiological Catchment Area 
research study done from 1980-1985 and 1990-1992.  The NIMH National Comorbidity Survey 
Replication (NCS-R, 2003) also suggested similar statistics while other studies indicate even 
higher annual point prevalence rates of upwards of 35 million Americans or over 16% of the 
population (Kessler, et. al, 2005; Kessler, et. al. 2003).  
Chronic depression data suggest a prevalence rate of 3-5% while other studies report 
prevalence as high as 17% for the general population or community samples, and 9-31% for 
clinical populations (American Psychiatric Association, APA, Diagnostic Statistical Manual, 
DSM IV-TR, 2000). Despite, these large numbers, only one in three individuals seeks help and 
of those, it is estimated that less than 10% receive adequate treatment (Eaton, et. al, 2008; Berlim 
& Turecki, 2007; Keller, 2002). 
Similar to depression in general, there is a vast under-recognition and under-treatment of 
this chronic population. Also, ineffective conventional depression treatments are often applied to 
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these chronic patients and due to inadequate responses, chronic patients are often referred to as 
‗treatment resistant‘, ‗treatment refractory‘ or ‗treatment failures‘, although no consistent 
definitions exist for the terminology (APA, 2010; Keller, 2002). Overall, chronically depressed 
patients are at elevated risk for relapse, recurrence, heightened disease burden, costs and 
complications, resulting in an overall poor prognosis.  
Individuals with CD often have difficulties coping adequately with life stressors, have a 
history of developmental trauma, repeated interpersonal difficulties, and deficient coping tools 
that lead to feelings of hopelessness and helplessness (McCullough, et. al, 2003; Penza, et. al, 
2003). Thus, it can be speculated that the individual with chronic depression, over time engages 
in behaviors and thinking that reinforce specific psychosocial, interpersonal and biological brain 
pathways that are more consistent with depressive symptomatology (Penza et. al, 2003).  
Ultimately, these psycho-social and biological underpinnings enhance the likelihood of clinical 
depression, accounting for a more chronic course with reduced inter-episode remissions or 
symptom-free periods. 
Despite the significance and pervasive nature of this problem, depression benchmarks 
and practice guidelines do not exist specifically for chronic depression. Guidelines must be 
applied and tailored to this sub-population from the general depression or major depression 
evidence base (APA, 2010). General and major depression guidelines include a focus on accurate 
identification and screening for depression, early detection and evidence-based treatments (APA, 
2010; Druss, et. al, 2008). The majority of the data however focus on medication guidelines 
while few address psychotherapy approaches for depression in general, and none target chronic 
depression specifically. This project distilled current practice standards for depression as they 
apply to the specific nuances and challenges of chronic depression. Thereby, the evidence 
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supports the premise that screening for depression, the accurate identification of recognized 
subtypes of chronic depression, application of effective and early treatment with EB approaches 
is essential; hence another impetus for this educational workshop.  
       Section II   
 
    Introduction to the Evidence Critique  
 This section is divided into multiple sub-sections due to the complexity and breadth of 
the topic of depression and as it relates to chronic depression and treatment. Included is an 
introductory overview and summary of the evidence that precedes a more in-depth, analytic 
review and critique of the specific evidence in more focused areas related to chronic depression 
and psychotherapy modalities. The initial overview addresses a summary of the evidence 
regarding depression management in general and the specific evidence base for the identification 
and treatment of chronic depression. Also included in a following sub-section is information 
regarding a particular psychotherapeutic approach, Cognitive Behavioral Analysis Systems 
Psychotherapy (CBASP), to specifically manage chronic depression (Swan & Hull, 2007; 
McCullough, 2000).  Research discussing the challenges of chronic depression, appropriate 
identification, treatment resistance, and an evidence-based approach that considers the unique 
nature inherent to this disorder, are also presented in further sections.  
   Overview and Summary of the Evidence  
To summarize, the majority of evidence supporting depression treatment in general is 
pharmacologically-based and while some guidelines exist for medication management, there are 
no guidelines for the management of chronic depression specifically, or for psychotherapeutic 
approaches to CD. The literature consistently supports that medication monotherapy provides 
some relief of acute depressive symptoms and psychosocial functioning; however the overall 
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efficacy is inadequate, particularly with the chronic population (Trivedi & Kleiber, 2001; 
Anderson, Nutt & Deakin, 2000; Howland, 1993a; Miller, et. al, 1998; Rush, et. al, 1998).   
 There is also a consensus in the field that manual-based or protocol-driven 
psychotherapies combined with medications are the gold standard for depression treatment but 
little empirical evidence exists to support specific manual-based therapies in general let alone for 
chronic depression (Weissman, 2007; Markowitz, 1994).  Notably, CBASP is the only manual-
based psychotherapy modality that has been tested and shown to be efficacious for chronic 
depression specifically (McCullough, 2003; Keller, et. al, 2000), despite widespread use of other 
modalities in the field for this population.  Thereby, clinical and expert consensus that manual-
based therapies can be effective, at least one, in this case, is supported.  However, comparative 
psychotherapy trials for chronic depression have not yet been published. One recently published 
protocol (Wiersma, et. al., 2008) stated the intent to study ‗usual secondary care‘ with 
medication and CBASP with medication to compare the overall effectiveness and cost efficacy 
of the two combination modalities. This potential multi-site study planned in the Netherlands has 
yet to be published but could enlighten the issue further.  
 Overall, the literature supports the premise that chronic depression is indeed different 
from non-chronic depression, but does not adequately respond to conventional depression 
treatment, and remains a significant problem for those affected (Michalak & Lam, 2002; 
Howland, 1993a; Howland, 1993b; Kessler, et. al, 1993; Scott, Barker, & Eccleston, 1988). 
Specifically, the evidence reviewed implies that the impact of chronicity is analogous to an 
increased likelihood for relapse and recurrence, disease burden, as well as diminished response 
to treatment (i.e. treatment resistance) (Michalak & Lam, 2002; Tranter, O‘Donovan, 
Chandarana, & Kennedy, 2002; Kornstein et. al, 2000; Miller, et. al, 1998; Keller & Hanks, 
  Chronic Depression     14 
 
1994; Thase, 1992; Keller, Lavori, Rice, Coryell & Hirshfeld, 1986).  The evidence also supports 
the idea that clinicians often do not recognize depression in general let alone chronic patients, 
and even when they are noted, ineffective and inappropriate treatment modalities are applied 
(Keller, 2003; Weissman & Markowitz, 2003; McCullough et. al, 2003; Michalak & Lam, 2002; 
McCullough et. al, 1996; Markowitz, 1994).  
 Further evidence supports the identification of subgroups of chronic depression 
(McCullough et. al, 2003; Michalak & Lam, 2002; McCullough et. al, 1996; Scott, Barker, & 
Eccleston, 1988) although again no guidelines exist for identification or treatment once a patient 
and depression subtype is correctly identified. The American Psychiatric Association (APA, 
2010, October) and the United States Preventive Services Task Force (USPSTF 2002) have 
proposed guidelines for screening adults for major depression and depression in general 
respectively, and maintain that proper screening and diagnosis improves clinical outcomes 
(2010; 2002).  However, no treatment guidelines exist specifically for chronic depression 
identification, management or follow-up and maintenance. A few randomized control trials 
(RCT‘s) of chronic depression compare treatments that depart from conventional depression 
management and suggest future implications for care and this paper will discuss them. 
 Please refer to Appendix B for the analytic methods used to critically appraise existing 
literature in the following sections and Appendices C and D for the specific articles reviewed. In 
addition, based on the available evidence, practice guidelines for chronic depression have been 
developed despite significant gaps in the knowledge base (See Appendix E).  A detailed text 
summary of the practice guidelines is also included in Appendix F.  
   Detailed Review and Critique of the Evidence 
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Critique First Search Category: Chronic Depression Identification, Screening, and Disease 
Impact 
 Several articles in the initial search on the identification of chronic subtypes and disease 
impact revealed primarily expert opinion pieces (Trivedi & Kleiber, 2001; Howland, 1993a; 
Howland, 1993b; Scott, Barker, & Eccleston, 1988), although one excellent review article of key 
randomized controlled trials (RCT‘s) was elucidated as well and is deemed good quality, type I 
(See Appendices C, D & E; Michalak & Lam, 2002).  Another article indirectly discusses 
chronic depression by citing that one-third of depression patients are non-responders and 
inferring that they incur a chronic course (Katon & Sullivan, 1990) but due to the remote date, 
opinion only,  and lack of specificity to chronic depression, it is poor quality for the purposes of 
this review.  In general, recent good quality evidence was scarce. The expert opinion manuscripts 
are overall considered fair quality evidence (USPSTF, 2002; See Appendix C) in that they are 
limited in number and have remote dates of publication, but are nevertheless consistent in their 
conclusions.   
 Only two well done and thorough review articles were located (Michalak & Lam, 2002; 
Angst, 1997) and the 1997 article reported data derived from longitudinal outcome studies 
(1966-1997) that depressive disorders often become chronic in 25% of patients (Angst, 1997). 
Both are considered good evidence (USPSTF, 2002) despite the Angst article being somewhat 
older.  Moreover, only one, more recent, large descriptive study of chronic depression 
nomenclature, was located and it was derived from a rigorous well-designed RCT of 681 
outpatients (incidentally the same study that is discussed later in this paper in the RCT‘s section 
concerning the efficacy of CBASP) (McCullough, et. al, 2003; Keller, et. al, 2000).  
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 All the aforementioned articles consistently discuss the symptom criteria for the 
identification of chronic depressions listed in the Diagnostic and Statistical Manual (either DSM-
III-R or DSM-IV depending on their publication date), which is considered the gold standard and 
currently accepted American Psychiatric Association‘s (APA) empirically-based psychiatric 
diagnoses (2000, 1994).  Due to the common reference to the APA‘s DSM, there was agreement 
in chronic depression definitions amongst all articles and is considered good evidence (See 
Appendices C & E). Moreover, these articles cited similar prevalence rates for chronic 
depression subtypes from 3-5% and 9-31% in community and clinical samples respectively. 
 Similarly, there is a consensus that no evidence exists for chronic depression 
identification rates but there is significant evidence for poor prognosis, treatment resistance and 
high co-morbidity rates, even when chronic depression is correctly identified. The authors agree 
that the evidence supports that significant numbers of chronic patients receive suboptimal 
treatment if any treatment at all. This data is consistent with depression data in general and so it 
is considered fair quality as it may have external validity and be considered applicable to a wider 
population, type IV or V (expert panel or opinion pieces; See Appendices C, D, & E) despite the 
lack of empirical research support needed to earn a good quality or type I-A (See Appendices C 
& D) rating per the criteria chosen for this review.  
 Some of the evidence discusses the premise that if and when chronic depression is 
identified correctly, there are poor outcomes and inadequate treatment (Michalak & Lam, 2002; 
Keller, et. al, 2000). Thus, screening is considered by several experts (opinion pieces, type IV or 
V; See Appendix D) in the field to be an important step in terms of appropriate identification. 
Several opinion articles suggest a variety of methods for appropriate screening for chronic 
depression although there is little specific agreement or evidence to support any one particular 
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method (Keller, 2003; See Appendix E).  No current best-practice guidelines exist for screening 
chronic depression, although the USPSTF indicates screening for adult acute (non-chronic) 
depressions improve outcomes (Pignone, et. al, 2002) and other evidence-based guidelines for 
depression in general, have also have also been clinically generalized to include chronic patients 
(Anderson, Nutt, & Deakin, 2000).  Thus, the quality of this evidence is also somewhat 
consistent and thereby fair quality, but similarly has the problem of a lack of specificity to 
chronic depression. 
 In addition, several of the expert opinion pieces (type IV or V as per Appendix D criteria) 
identify specific methods for identification and screening but only one recent rigorous and well-
designed, multi-site, large RCT provides strong data that the utilization of depression self-report 
questionnaires is helpful in identifying chronically depressed outpatients (Rush, et. al, 2005). 
Hence, this latter article is the only evidence specific to chronic depression with a type I-A good 
quality rating (See Appendix E).  However, a significant gap in the data in general, is that many 
chronically depressed patients are not in treatment, and or may only come into contact with 
service providers through primary care. Primary care is a level of prevention and care that still 
shows abysmal detection rates (30-50%) for depression in general, let alone chronic depressions 
(Pignone, et. al, 2002; Trivedi & Kleiber, 2001; Goldman, Nielson, & Champion, 1999).  
 The next search area included the impact of chronicity or treatment resistance and any 
guidelines for identification, screening and management. After discovering that there is minimal 
evidence concerning chronic depression specifically, the search was expanded to depression in 
general to try to elucidate chronic references by including the term ‗treatment resistance‘ but 
again this search yielded little additional evidence.   
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Summary of Search Category One: Chronic Depression Identification, Screening, and Disease 
Impact 
 Thus, the initial search of articles provided information confirming the unique impact of 
chronic depression and the identification of specific subtypes of the disorder. The evidence 
revealed through Medline, NCBI-pub med and Google scholar searches consistently supports the 
premise that chronic depression does indeed differ from episodic and recurrent depression and it 
is typically viewed as having four to five subtypes depending on the authors‘ use of defining 
criteria. Generally speaking however, there is a lack of evidence specific to chronic depression 
and much of the evidence is based on depression in general and extrapolated by experts to 
include chronic depression. Screening is an area that is considered necessary but there is little 
agreement in terms of the best approach. 
Critique Second Search Category: Treatment 
 This search area generally revealed that there is scant empirical evidence for chronic 
depression from identification and screening through management. However, numerous well-
constructed research articles provide evidence for the benefits of a unique treatment approach to 
the chronic depression problem.  Eight of the articles look at different aspects from one large, 
well-designed, randomized, double-blind, multi-site, clinical, comparative treatment trial, 
including the specific psychotherapeutic modality for chronic depression, CBASP. Additional 
smaller rigorous studies also support these initial research findings. Overall, this compilation of 
data is the strongest evidence to date and is deemed good quality type I-A (See Appendix E), due 
to the specificity with regards to chronic depression, recent dates of study, large sample sizes, 
and strong randomized designs. These well-designed quality studies generally all support the 
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efficacy of CBASP alone and even superiorly in combination with medication for chronic 
depression treatment and with specific psychopathological co-morbidities.  
Detailed Evidence Base Summary for CBASP  
The first and perhaps most prominent study was published by New England Journal of 
Medicine (NEJM) in 2000 by Keller and colleagues and attempted to determine the relative 
efficacy of medications and psychotherapy for chronic depression. In this national multi-site 
study, 681 outpatients (18-75 years) with chronic non-psychotic unipolar major depression were 
randomly assigned to either 12 weeks of antidepressant treatment, Nefazodone (Serzone 
maximum daily dose 600 mg), or 16-20 sessions of CBASP, or a combination of Nefazodone 
and CBASP therapy. Nefazodone, a post-synaptic serotonin receptor antagonist (5HT-2) 
moderately inhibits both serotonin (5HT) and norepinephrine (NE) reuptake and has been shown 
efficacious with depression in general (Denton, et. al., 2010; Keller, et. al., 2000).   
Notably, one of this study‘s and the associated protocols‘ largest limitations is that there 
is no comparative psychotherapy group or ‗placebo‘ control therapy group structured into the 
design, such as a ‗usual treatment‘ circumstance (i.e. what a typical patient might encounter at a 
general health or mental clinic). Despite these limitations however, roughly half (48%) of the 
patients in this particular study had a response to either Nefazodone or CBASP, but the 
combination treatment was significantly superior (73% response) to either treatment group alone 
(Keller, et. al, 2000). Thus, the combination of  Nefazodone (Serzone) and CBASP was found to 
be more efficacious than either treatment alone in CD . CBASP was equal in efficacy to Serzone 
after 12 weeks and again after 4 months of monotherapy. In addition, 85% of responders after 12 
weeks  of treatment maintained the treatment response in the 4 month continuation phase (Keller, 
et. al, NEJM, 2000) 
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This data is consistent with studies looking at recurrent and episodic depression and 
consensus findings that combination medication and Cognitive Behavioral Therapy (CBT), an 
EBP for depression in general, are efficacious. These findings are relevant to clinical practice 
since in the era of managed care; many patients with depression are started on medication 
treatment alone and not in psychotherapy due to access, preference, cost, time and insurance 
coverage issues. However, due to the complexity and treatment challenges of CD, most chronic 
patients are started on medications initially. Thus, the improved outcome data described in this 
well-constructed large study mandates further consideration by providers for the use of a 
combination of CBASP and medication therapy for chronic patients. 
A second study, found that 12 weeks of CBASP appears to be efficacious for non-
responders to Nefazodone in a crossover design of chronically depressed adults from 12 
nationwide sites (Schatzberg, et. al, 2005). The research focused on three subtypes of chronic 
depression; chronic major depression, double depression, and recurrent major depression without 
full inter-episode remission (See Appendix A and Figures 1, 2 and 3). This study is notable for 
being the first prospective controlled trial to evaluate the efficacy of psychotherapy following 
non-response to an antidepressant trial. It is further significant because a large proportion of 
depressed patients do not respond to initial trials of either medication or therapy, called stage I 
antidepressant resistance (Schatzberg, et. al, 2005). Few empirical guidelines exist in assisting 
treatment approaches and thus this study is an important premier step in that process.  
Similarly, Koscis and colleagues demonstrated that combination treatment (Nefazodone 
and CBASP) may carry protective effects against relapse. The authors found that combined 
therapy was associated with less symptom re-emergence during continuation compared to either 
monotherapy after 16 weeks (2003), and during maintenance compared to the control group 
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consisting of only follow-up assessments (Klein, et. al, 2004). Additionally, CBASP was found 
in another related study to have significant effects on psychosocial functioning independent of 
depressive symptom changes, demonstrating that regardless of how much or little improvement 
in depressive symptoms occurs, there is still significant improvement in overall life functioning 
in those patients who engage in CBASP regularly (Hirschfeld, et. al, 2002).  
CBASP may also be an essential element in the treatment of patients with chronic forms 
of major depression and with a history of childhood trauma. Not all that surprisingly, in this 
study, chronic depression patients who reported a loss of parents at an early age, or a history of 
physical, sexual abuse or neglect, improved more with CBASP monotherapy than with 
antidepressant therapy alone. Similar to previous studies, the combination treatment of 
antidepressant and CBASP was superior to either singular treatment in the child abuse cohort 
(Nemeroff, et. al, 2003).  This is significant since 50% of chronic patients have co-morbid 
psychopathology (Keller, et. al, 2000). 
Another recent study found that the combination of CBASP with Nefazodone was twice 
as successful and CBASP monotherapy was superior to medication alone after 12 weeks of 
treatment in terms of dyadic discord (marital, couples, long-term intimate partnership 
dissatisfaction).  In this study, both CBASP alone and in combination with Nefazodone were 
found to more effectively reduce the severity of depressive symptoms than medication alone. 
One limitation in this study was that the reported data improvements were from the patient only 
and the partner was not assessed. However, valid and reliable measures were used in this study 
enhancing the rigor (also used in all of the aforementioned protocols) including: the 30-item 
Inventory of Depressive Symptomatology–Self-report (IDS-SR-30), the Hamilton Rating Scale 
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for Depression (HRSD), the Social Adjustment Scales (SAS), the Marital Adjustment Scale 
(MAS, this study only) (Denton, et. al, 2010).  
In another offshoot study Blalock and colleagues (2008) analyzed data from the seminal 
Keller study (2000), and found that a combination of CBASP with Nefazodone was successful in 
improving maladaptive cognitions and coping, especially with escape-avoidance coping 
(Blalock, et. al, 2008).   
Similarly, another effort stemming from the Keller study (2000), found CBASP to be an 
effective long-term treatment for CD. In this particular analysis, CD responders (n=82) to acute 
(12 weeks) and continuation phases (16 weeks) with CBASP were randomized to one year of 
monthly CBASP or ‗Assessment-Only‘ sessions. The findings included that significantly fewer 
CBASP group patients experienced recurrence (Klein, et. al, 2004).  
Finally, a patient‘s therapeutic skill acquisition and response to psychotherapy, alone or 
in combination with Nefazodone, was analyzed from the Keller and colleagues (2000) original 
data. Even though differences were demonstrated in terms of the speed of depressive symptom 
reduction, with combination treatment being superior, there were no differences found in the rate 
or overall level of skill acquisition when comparing CBASP alone to combination therapy. In 
fact, CBASP alone was found to be just as effective, even though combination treatment brought 
about more rapid symptom reduction; a more efficient process, perhaps implicating a synergystic 
response. However, that authors concluded from their results that medication alone does not 
enhance skill acquisition or effective participation in psychotherapy in CD patients who are 
doing CBASP (Manber, et. al., 2003).  
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Summary of Second Search Category: Treatment 
 Additional research concerning treatment for chronic depression does not address specific 
combination (medication and psychotherapy) approaches although one rigorous review article of 
RCT‘s suggests that combination medication and psychotherapy is the optimal approach for 
chronic depression. Thereby, there appears to be consensus in the evidence that combined 
modalities are optimal for chronic depression adding strength from this expert review to the 
aforementioned studies reviewed.  However, there remains little consensus as to which 
therapeutic modality is most efficacious in the review manuscript. Thereby, it is difficult to 
conclude since the main limitation of all of the aforementioned trials is the lack of a control or 
psychotherapy group, and with no comparative psychotherapy trials to date little evidence 
currently exists to support any one modality over another.   
 In summary, the findings in this area indicate that CBASP alone or in combination is 
efficacious for the treatment in both the short-term and maintenance treatment of chronic 
depression. However, extensive gaps remain in the treatment knowledge base and confirm the 
need for future research of modalities designed to further manage this unique disorder that depart 
from traditional depression treatment approaches and compare efficacies of those approaches.   
Critique of Third Search Category: Evidence-Based Guidelines for Depression 
 Cochrane, Ovid, National Institutes for Health and Clinical Excellence (NICE), Institute 
for Healthcare Improvement (IHI), National Guideline Clearinghouse, and the Center for Disease 
Control (CDC), searches yielded no evidence of empirically supported guidelines for the 
identification and or treatment of depression, let alone chronic depression. The Agency for 
Healthcare Research and Quality (AHRQ), National Institute of Mental Health (NIMH), and 
World Health Organization (WHO) databases revealed one article each, with the most recent and 
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specific being the Texas Medication Algorithm Project for chronic depression, an expert opinion 
piece (Trivedi & Kleiber, 2001; See Appendix E). The authors suggest identification of chronic 
depression subtypes and the progressive steps for treatment starting with specific options of 
medication monotherapies to later treatment with psychotherapy in general. No detail however is 
offered as to optimal type or duration of psychotherapy and it is almost mentioned as an 
afterthought without much empirical support.  Thereby, this evidence is not especially helpful 
and is considered type V-B fair by the standards (See Appendices C, D & E) since it is an expert 
opinion article, insufficient in scope, but does pertain to chronic depression specifically. 
However, this piece adds to the consensus data regarding subtypes of chronic depression.  
 The American Psychiatric Association (APA) recently published, for the first time in 
over ten years, new Practice Guidelines (PG) on October 1, 2010 for MDD (APA, 2010; Brauser, 
2010). The updated treatment guidelines for adult major depression include new evidence-based 
recommendations compiled from a review of over 13,000 scientific articles published from 
1999-2006.  An independent review board without ties to the pharmacological industry 
acknowledges relationships and the perception of potential industry conflicts of interest by the 
authors but pronounces the manuscript to be free of ostensible bias MDD (APA, 2010; Brauser, 
2010). 
 These new practice guidelines (APA-PG) primarily discuss medication strategies with 
brief mention of CBT and other interpersonal, psychodynamic and group therapies (2010). There 
is scant discussion of chronic depression overall in the 152 page document and no mention of 
CBASP is included.  There are no guidelines for chronic depression specifically, although 
Dysthymia, Double Depression, and Chronic Major Depression are alluded to as chronic mood 
disorders and the combination of pharmacotherapy and psychotherapy are suggested as superior 
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to monotherapy (APA, 2010), in concurrence with the clinical trials discussed in a previous 
section of this paper.  However, no specific psychotherapy modality is discussed and it is 
reported that ―Unfortunately, clinical trials provide little evidence of the relative efficacies of 
particular agents‖ (p. 62) in terms of medication for these chronic disorders.  
 In addition, the guidelines tout the superiority of combination psychotherapy and 
medication for treatment resistant or ‗non-response‘ and allude to ‗depression-focused‘ 
psychotherapy as augmentation strategies for non-responders but few additional details are noted 
(APA 2010). In particular, psychotherapy (cognitive-behavioral therapy CBT, cognitive therapy, 
CT, behavioral therapy, BT, or interpersonal therapies, IPT) with antidepressant medications are 
recommended for the initial treatment of moderate to severe depression (APA, 2010).  In the 
initial treatment of milder depressions, psychotherapy alone was found to be helpful especially 
when there are psychosocial stressors, interpersonal, or intra-psychic problems, and or co-morbid 
personality disorders; all issues with particular relevance to chronic depression. In addition, the 
guidelines purport that CBT and IPT psychotherapy are less effective than pharmacotherapy 
alone for chronic depression acutely (APA, 2010). The APA-PG propose that psychotherapy 
may ―foster the development of social skills and confidence after years of depression-related 
impairments‖ (2010, p, 47) another item with particular significance to the CD population and 
supported in literature. Thus, few guidelines exist to date specifically for chronic depression. 
 The only other article providing a guide to depression treatment is somewhat outdated, a 
2000 revision of the 1993 British Association for Psychopharmacology guidelines for treating 
depressive disorders in general (Anderson, Nutt & Deakin, 2000; See Appendix E). These 
guidelines were developed for antidepressants alone, with no mention of psychotherapy models 
and no application to chronic depression specifically, but formulated based on extensive review 
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of the literature and expert consensus. Therefore, the evidence is here is considered type IV-B, 
fair quality, although not especially helpful for the specificity of the present topic.   
Summary of Third Search Category: Evidence–Based Guidelines  
 Thus, few evidence-based guidelines are published and none are ideal or fully adequate 
with regards to the specificity of chronic depression treatment and psychotherapy.  
Critique Fourth Search Category: Expanded search for generalized depression psychotherapy  
 There exists an overwhelming amount of evidence for non-chronic depression traditional 
treatment modalities but detailed critique falls beyond the scope of this paper. The consensus in 
this information base considers that depression in general is a treatable disorder, with favorable 
treatment responses pharmacologically, and most optimally in combination with specific types of 
psychotherapy including; Cognitive and Behavioral Therapies (CT, BT and CBT), Interpersonal 
Therapy (IPT), and Psychodynamic psychotherapy.   
 Much of the psychotherapy literature includes studies of empirically-validated 
psychotherapy for major depression by at least two different investigators, conducted 
occasionally with manuals, and at least two between group and randomized controlled designs, 
primarily focused on non-chronic Major Depressive Disorder (MDD) and the following specific 
modalities: Behavior Therapy (BT) (Jacobsen, et. al, 1996; McLean & Hakstian, 1979), 
Cognitive Therapy (CT) (Medvide,  2005; Dobson, 1989), Cognitive Behavioral Therapy (CBT) 
(Gloaguen, Cottraux, Cucherat, & Blackburn, 1998; Elkin, et. al, 1989), and Interpersonal 
Therapy (IPT) (DiMascio et. al,1979;  Elkin et. al,1989).  In general, the evidence is type I-II and 
A-B, good to fair quality, and supports a variety of psychotherapy approaches that are widely 
embraced in the field for non-chronic depression. Again, no comparative psychotherapy trials in 
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particular for chronic depression are published, and thus this significant gap mandates further 
study.  
Summary of Fourth Search Category: Expanded search for generalized depression 
psychotherapy    
 Despite agreement regarding the efficacy of many of these conventional psychotherapy 
approaches for non-chronic depression, the evidence supports the premise that there remain 
significant numbers of depressive patients who do not respond or only partially respond to 
treatment, and or relapse into a more chronic course, often associated with high psychiatric and 
medical co-morbidities, as well as societal costs (Keller, et. al 2000; Keller, et. al, 1998a; 
Howland, 1993; Thase, 1992).  Many of these patients are likely unrecognized chronic patients, 
highlighting the need for further depression symptom, pattern and chronology assessment and 
research. Thus, while the lack of empirical evidence in this area does not negate the efficacy of 
CBASP, the evidence generally supports a deficiency of these traditional psychotherapy 
approaches with regard to chronic depression and the new APA-PG support this idea (APA, 
2010). Thereby, it is difficult to discern relative quality of therapy across modalities without 
further comparative trials and research. Thus, it behooves clinicians to ultimately choose the only 
demonstrated efficacious evidence-based approach, CBASP, pending further convincing 
psychotherapy research. 
Critique Fifth Category Search: Manual-Based Psychotherapies 
 While there has been an information explosion for evidence-based medication therapy for 
major depression (APA, 2010) and depression in general, lesser recognized psychotherapy 
practices and in particular, protocol-driven or manual-based psychotherapies (such as those 
discussed in the previous search section), are consistently proposed to be the most effective by 
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experts in the field (Weissman 2007; Weissman & Markowitz, 2003). Again however, little 
empirical evidence exists to support these opinions specifically for chronic depression (with the 
exception of CBASP).  
 Thus, departing from monotherapy with medication, the evidence exists predominantly as 
expert opinion articles touting manual-based psychotherapies as optimal for treating depression 
typically in combination with medications. Only one 1992 meta-analysis of 11 studies was 
discovered that reviewed the efficacy of manual-based, brief dynamic psychotherapies alone and 
in general (i.e. not merely for depression) and thus is considered poor quality evidence for the 
purpose of this paper, due to the remote date, lack of generalizability to chronic depression, lack 
of combined modalities, and the limited number of articles. The article highlights that one of the 
largest challenges in these types of studies is a lack of control and treatment variable specificity 
(Crits-Cristoph, 1992) which again adds to the poor rating. 
Summary of Fifth Category Search: Manual-Based Psychotherapies 
 Ideally, adequate screening and prevention of recurrent depressive episodes may 
ultimately become the primary approach to the development of chronic depression, but 
inconsistent guidelines and data fail to demonstrate what evidence works best.  Although many 
authors in these expert opinion and review pieces cite this premise, exhaustive searches resulted 
in no chronic depression treatment or screening guidelines and yield a general lack of empirical 
evidence in this area. Additionally, while experts similarly tout the use of manual-based 
psychotherapies, little empirical support for their efficacy in chronic depression exists, with the 
sole exception of the RCT‘s that support the efficacy of CBASP, a manual-based psychotherapy 
alone and in combination with medication.   
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 Thus, much evidence from the arena of non-chronic depression has been generalized to 
chronic depression somewhat inadequately, highlighting the need for further study. The primary 
gaps in the data are best screening tools and identification procedures, comparative 
psychotherapy trials, alone and in combination with medications as well as maintenance and 
follow-up guidelines for relapse, and relapse-prevention strategies. 
       Section III 
     
      Implementation Plan  
 
 The conception for the workshop originated and developed from personal training in 
CBASP, experience with its efficacy and an interest in broadening the knowledge and use of 
aspects of the modality in a more accessible manner in line with the WHO initiative. Despite the 
demonstrated efficacy and effectiveness of CBASP for over a decade, the certification and 
training process are rigorous, timely and expensive. Thus, few CBASP providers exist and as a 
modality, it remains not widely recognized or applied. Market analysis indeed supports that few 
CBASP providers exist locally (See Appendix G Market Analysis). There are probably 
numerous reasons for this particular outcome, but according to James McCullough PhD, CBASP 
founder, to become a CBASP provider involves a time-consuming process that includes 
(intensive training) plus ongoing weekly supervision via video (for 4-5mos), and the use of a 
provider skills manual (2003, 2000). In addition, to become a ‗certified‘ CBASP provider, incurs 
even more time, ratings, inter-rater reliability, and additional training and supervision 
(McCullough, 2003). 
 Thus, the modality is not easily accessible to most providers, let alone patients. The 
therapy was originally tested and conceived to be 1-2x/week hour-long sessions with homework 
in between, imposing further barriers to accessibility and application (See Appendices H & I for 
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CBASP characteristics and implementation details). While access is limited, expensive, 
intensive, and time-consuming, many patients may not be able to use therapy even when 
accessible, due to other restrictions, such as current economic and health care insurance 
limitations. The workshop premise evolved as an opportunity to bring a synthesis of specific 
CBASP strategies to more providers in a broader way, analogous to how CBT or IPT are now 
widely used with varied application across specialties. Thus, the workshop was designed with a 
mix of didactic and interactive simulation and case vignette exercises for practical application for 
use ‗in-the moment‘ by the provider with any patient encounter.  
 Specific implementation included a trainer with specialty experience and knowledge of 
CBASP and the development of teaching materials (See Appendix J for Workshop Course 
Outline and Attached Cox CE Workshop Packet from October 2, 2010). Potential participants 
were targeted through mental health websites, postal and e-mail addresses, intra and inter-
professional contacts, as well as electronic postings, e-flier announcements (See Appendix K for 
Workshop E-flier) and a USF alumni mailing list (yielding >3000 addresses), as well as San 
Francisco/Bay Area mental health, inpatient and community health settings via postcards and 
electronic advertising fliers. 
 The workshop‘s overarching objective was to distill key approaches from a complex 
evidence-based psychotherapy modality for community providers to impact current practice. The 
educational intervention‘s aim was to provide the distilled evidence-based strategies in an 
accessible ―Tool Kit‖ to a variety of community and mental health providers, and to seize 
opportunities for patients to experience these approaches that might not otherwise have the 
chance.  The workshop was viewed as an opportunity to apply the concepts and tools of this 
EBP, in a wider more accessible and more frequent way to mental health professionals who 
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come into regular contact with chronically depressed patients and can interact with them ‗in-the-
moment‘ in the community, inpatient settings, clinics, at the bedside, and even in the patient‘s 
homes.  
 The underlying idea of distilling the conceptual CBASP strategies and presenting the 
synthesized ‗Tool Kit‘ was to impact current practice by changing the treatment environment, 
and from a culturally competent standpoint, bringing these approaches to the patient in his/her 
environment. This idea ultimately fits exceptionally well within the CBASP perspective since 
one of the underlying concepts is that the CD patient is disconnected from their environments 
and the clinician role is to reconnect them. Provider participants were thereby encouraged to 
bring the tools back to their respective clinical settings and adapt them in ways that work for the 
patients and the setting; recognition that one size does not fit all was essential and this 
application process was evaluated.  
 Specifically, the two main educational intervention workshop objectives were: 1). To 
improve participants‘ knowledge-base in the identification of chronic depression (CD) patients 
and, 2). To introduce and synthesize therapeutic strategies and tools from Cognitive Behavioral 
Analysis Systems Psychotherapy (CBASP), an Evidence-Based psychotherapeutic (EBP) 
approach for the treatment of CD, to impact current practice. The continuing education (CE) 
objectives for the Board of Registered Nursing (BRN) and Board of Behavioral Sciences (BBS) 
were to: 
1. Learn to accurately identify chronic depression (CD).  
2. Learn evidence-based strategies to work more effectively with chronically depressed clients. 
3. Learn tools from Cognitive Behavioral Analysis Systems Psychotherapy (CBASP), a 
therapeutic modality, specifically designed for treatment of chronically depressed clients.  
4. Practice therapeutic strategies for the management of chronically depressed clients. 
5. Recognize common problems associated with the CD patient and treatment approaches. 
6. Identify resources for the CD patient and provider. 
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 The workshop was held from 8:45am until 5:00pm and the course outline is provided (See 
Appendix J). From 9:15 to 10:15am the workshop‘s morning session officially opened with the 
educational content and slide show addressing ‗What is Chronic Depression?‘.  The unique 
aspects of chronic depression, the subtypes, treatment challenges as well as strategies and tools 
for CD identification, monitoring and application were also presented. Throughout the workshop, 
participation and discussion were encouraged, and attention was given to additional resources 
and educational items for application in the corresponding Cox-CE folder and resource packet.  
A break was offered from 10:15 to 10:30 am followed by another hour a half of content 
including, the introduction to CBASP, and an overview of the tools and evidence-base. This 
section started with a role play of the case presented in the pre-assessment, Evaluation A, to 
demonstrate a typical CBASP approach and highlight the similarities and differences from more 
traditional psychotherapy practices.  
  The afternoon session opened with an hour and forty five minutes of content addressing 
the specific CBASP Skills including, the strategies and official "Tool Kit‖ along with practical 
exercises for each tool. The tools included specific CBASP strategies such as: the significant 
other history (SOH), situational analysis (SA), assertiveness and interpersonal discrimination 
exercises (IDE), the proactive use of transference and negative reinforcement, maintaining an 
active patient role and the patient‘s ‗attentional focus‘, highlighting maladaptive patient 
cognitions and a facilitative provider role with disciplined personal involvement, and mood 
monitoring tools and evidence-based measures; all synthesized in a fashion to be utilized in-the-
moment with patients.  Another brief 15 minute break was offered and from 3:00 to 4:30 pm an 
interactive discussion including group work and simulation case exercises for practical 
application was included.  From 4:30 to 5:00 pm, a wrap-up with concluding summary 
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statements, additional resources offered and dissemination of the post-assessments and reminders 
regarding the two- week follow-up survey were done to conclude the workshop.  
Consistent with the WHO initiative (2010), implementation of the workshop is deemed a 
timely, evidence-based, effective and efficient venue to present relevant information to a broad 
variety of mental health and community providers. The endeavor inherently was designed to 
heighten awareness of the chronic depression problem and allow any participant an equal 
opportunity to learn, adapt and disseminate the therapeutic strategies and tool kit (See Appendix 
L for Workshop Tool Kit) in their respective professional settings, in a patient-centered and 
culturally competent manner.  
The original workshop goal was to obtain a minimum of 10 participants with a maximum 
capacity for this type of learning format set at 25 attendees. The official number of registrants 
was 20 plus two doctorate- prepared nurse assistants, who participated in the workshop but not 
the evaluations (due to their assistance in the development of the workshop and evaluative 
measures), and the trainer for a total of 23. Two student assistants also helped with the program 
event including registration and administrative support, but also participated in the workshop and 
the evaluations and thus are counted in the evaluative measures. Thus, the actual number of 
participants who attended and participated on October 2
nd
, 2010 was 19 minus the two nurse 
assistants for an N=17 for the evaluation purposes. Thus, the minimum participant goals were 
exceeded. USF Institutional Review Board (IRB) approval was obtained. The board determined 
the project to be safe and declined the need to further evaluate the project based on the premise 
that it is a continuing education (CE) workshop and an educational intervention with no 
manipulation of subjects.  
      Section IV 
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     Evaluations Overview  
 
 Four evaluations were disseminated to all workshop participants. A pre-assessment, 
Evaluation A, and two post-workshop Evaluations B (event day) and D (a two week follow-up 
survey) were distributed and queried demographic information and content knowledge in a 
multiple choice format (See Appendices M, N and P). Each evaluation also included one case 
study exercise to offer an opportunity for participants to qualitatively respond from the provider 
perspective. An evaluation of the offering, Evaluation C, was also dispensed at the close of the 
workshop to meet board requirements (See Appendix O). Outcomes data were analyzed and 
compiled (See Tables III through XVI below for summary data and Tables XVII through XIX 
after the Appendices for individual participant outcome data). 
More specifically, the first evaluation or pre-assessment (Evaluation A, See Appendix M) 
was dispensed during the morning registration period and queried demographic and professional 
information as well as pre-workshop content knowledge. Every evaluation (except Evaluation C 
for the offering) was assigned an identifier number so that answers were confidential (not 
anonymous), in order to compare pre and post-workshop individual participant responses. The 
post-assessment (See Appendix N for Evaluation B) was dispensed at the close of the workshop 
and collected as participants departed. The evaluation of the offering (See Appendix O for 
Evaluation C), a Board of Registered Nursing (BRN) and Board of Behavioral Sciences (BBS) 
requirement, and the two week post-assessment follow-up survey (See Appendix P for 
Evaluation D) will be discussed separately in later sections.  
In Evaluations A, B and D, the participants were asked to write a brief response to each 
case scenario with potential provider and client responses. The idea was to see if any CBASP 
tools or principles were applied in their responses to each case.  Three ‗expert‘ raters coded each 
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of the participants‘ responses based on a numerical key (See Appendix R). The ‗expert‘ raters 
included: a CBASP trainer and two additional raters with prior knowledge of CBASP who also 
attended the training (but did not participate in the evaluations except in terms of development). 
All three raters were blinded to each other‘s responses and coded every participant‘s response to 
each of the three cases. The participant responses were transcribed verbatim, then rated with an 
assigned numerical code (See Appendix R) and highlighted in Table III below. 
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                 Table III 
 
Comparison of Rater (R) 1, 2 and 3‘s assessment of each participant‘s responses to Eval A, B and D cases. 
 
Participant  
ID# 
Coded  
Responses Eval A 
Coded    
Responses Eval B 
Coded    
Responses Eval D 
2 
 
R1: 1, 5, 15 
R2: 1, 2, 3, 4, 5, 8, 18 
R3: 1, 2, 3, 4, 5, 8 
R1: 3, 8, 9, 10, 14 
R2: 2, 3, 5, 8, 9, 14, 18, 19 
R3: 3, 8, 9, 1, 14, 19  
R1: 5, 8, 10, 14, 18 
R2: 2, 3, 8, 9, 10, 12, 14, 15, 18, 19 
R3: 3, 8, 9, 10, 11, 12, 14, 15, 18, 19 
3 
 
Missing data.  
No response. 
 
R1: 3, 9, 14 
R2: 2, 3, 5, 8, 9, 14, 18 
R3: 3, 9, 14, 17 
R1: 1, 2, 3, 5, 10, 15 
R2: 2, 3, 4, 5, 8, 9,10,11,12,14,15,16,18 
R3: 2, 3, 5, 8, 10, 11, 15, 16 
5 
 
R1: 1, 2, 20 
R2: 1, 2, 8 
R3: 1, 2, 7, 20 
R1: 5, 8, 9, 14, 15 
R2: 2, 3, 5, 8, 9, 14, 18, 19 
R3: 2, 3, 9, 11, 14, 17, 19 
R1: 5, 10 
R2: 2, 3, 4, 5, 8, 9, 12, 14, 17, 18 
R3: 2, 5, 8, 9, 14, 18 
7 
 
R1: 1, 2, 3, 9 
R2: 2, 3, 8, 12, 16 
R3: 3, 4, 8 
R1: ‗?18?‘ 
R2: ‗not really a response‘ 
R3: ‗0, N/A‘ 
R1: 3, 4, 5, 9, 14 
R2: 2, 3, 4, 5, 8, 12, 14, 15, 17, 18 
R3: 3, 5, 8, 10, 14 
8 
 
R1: 3, 9, 14 
R2: 2, 5, 7,12, 16, 19 
R3: 3, 4, 7 
R1: 3, 15  
R2: 2, 3, 5, 7, 9  
R3: 3, 11, 15 
R1: 1, 2, 16 
R2: 1, 2, 16 
R3: 1, 2, 8, 16 
9 Missing data.  
No response. 
 
R1:8, 10, 14, 15 
R2: 2, 3, 4, 5, 8, 10, 12, 14, 15, 18 
R3: 3, 10, 12, 14, 15 
R1: 1, 2, 9, 14 
R2: 1, 2, 3, 4, 5, 8, 9, 11, 12, 14, 17, 18 
R3: 1, 2, 8, 10, 11, 12, 14, 15, 16, 20 
10 R1: 3, 9, 15, 20 
R2: 2, 3, 4, 8, 9, 14, 18 
R3: 4, 5, 6, 7, 20 
R1: 3, 10, 15 
R2: 2, 3, 4, 5, 8, 9, 10, 12, 14, 15, 17, 
18, 19 
R3: 3, 8, 10, 11, 12, 14, 15 
R1: 2, 3, 10, 14 
R2: 2, 3, 4, 5, 8, 9, 10, 11, 12, 14, 15, 
17, 18 
R3: 2, 3, 8, 9, 10, 11, 12, 14, 19 
11 R1: 1, 2, 9, 20 
R2: 1, 2, 8, 17, 18, 20 
R3: 1, 2, 4, 6, 7, 20 
R1: 1, 3, 9, 10, 14, 17 
R2: 1,2,3,4,5,8,9,10,11,12,14,15,16, 18, 
19 
R3: 1, 2, 3, 9, 10,  11, 14,15,17,18,19 
R1: 1, 2, 3, 5, 8, 9, 18, 19, 20 
R2: 1, 2, 3, 4, 5, 8, 9, 12,14,16,17,18,19 
R3: 1, 2, 3, 8, 9, 11, 14, 18, 19 
13 R1: 1, 2, 3, 8, 9 
R2: 2, 3, 8, 17, 18, 19 
R3: 2, 4, 7 
Missing data; not returned. R1: 3, 5, 10, 15 
R2: 2, 3, 4, 5, 8, 9, 10, 11, 12, 14, 15, 
17,  18, 19 
R3: 3, 5, 8, 9, 10, 14, 17, 19 
16 R1: 3, 9 
R2: 2, 14 
R3: 3, 7 
R1:  3, 8, 9, 14 
R2:  2, 3, 4, 5, 8, 9, 12, 14, 18 
R3:  3, 5, 9, 14, 18 
Missing data; not returned. 
17 R1: 3, 5, 8, 9, 14, 15 
R2: 1, 2, 3, 4, 5, 8, 9, 12, 14, 16, 
18 
R3: 1, 3, 5, 8, 9, 14, 16, 18 
R1: 3, 8, 9, 14 
R2: 2, 3, 4, 5, 8, 9, 14, 18, 19 
R3: 2, 3, 5, 9, 14, 18 
R1: 3, 5, 9, 19 
R2:  2, 3, 4, 5, 8, 9, 12, 13, 14, 15,18, 
19 
R3: 3, 5, 12, 15 
18 R1: 1, 3, 9, 14 
R2: 1, 2, 3, 5, 8, 9, 14, 18, 19 
R3: 3, 5, 8, 9 
Missing data; not returned. R1: 1, 2, 3, 9, 20 
R2: 1, 2, 3, 5, 8, 9, 11, 12, 14, 15, 18, 
20 
R3: 1, 2, 3, 9, 20 
19 R1: 3, 9, 11, 14 
R2: 2, 3, 8, 11, 14 
R3: 3, 7, 11, 14 
Missing data; not returned. R1: 1, 2, 11, 14 
R2: 1, 2, 3, 7, 9, 11, 14, 15 
R3: 1, 2, 3, 7, 9, 11, 16, 18 
20 R1: 3, 9, 14 
R2: 2, 3, 8, 14, 18, 19 
R3: 3, 7, 14 
R1: 1, 3, 8, 9   
R2: 1, 2, 3, 5, 8, 9, 14, 16, 18 
R3: 1, 2, 3, 5, 8, 9, 14, 16, 18 
Missing data; not returned. 
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The overall premise of the case scenarios was essentially to see if participants were able 
to apply CBASP tools and principles to the cases. Specifically, the idea was to discern if any 
common themes developed, or did the ratings capture any degree of agreement between the 
raters or any differences between the pre and post assessments. Despite a generally increased use 
of CBASP-tools in the post-assessments, as seen in the aforementioned table, there was little 
consistency in ratings between raters and even within each individual rater across items. 
Moreover, despite the strong intentions, there was no standardized training or practice with the 
measure and numerical codes. Thus, no definitive conclusions can be drawn due to a lack of 
rigor, internal validity, inter-rater and intra-rater reliability; potential issues to address in any 
future evaluative measures. 
    Pre-Assessment (Evaluation A) Results Summary 
 
Demographic data derived from the Pre-Assessment (Evaluation A, Appendix M), found 
the cohort of 17 respondents to be a diverse group in terms of age, ethnicity, educational 
background, professional roles and certifications. The majority of the group, or 41% of 
participants, reported that they are between the ages of 51-60 years while 24% fell into the 31-40 
year old age category. Eighteen percent identified as 41-50 year olds and 6% of participants each 
(or 3 individuals) had their own category from 20-30 years to 71+ years. The majority of 
registrants, or 71%, were women and 35% identified as Asian or Filipino, followed by 29% 
Caucasian and 18% Latino/Hispanic origin. Another 18% (or 3/17) chose not to respond to this 
cultural background item.  
In terms of educational background, 47% (8/17) reported a Master‘s degree or Master‘s 
of Science in Nursing (MSN) with one master‘s in nutrition, and 24% (4/17) attained a highest 
level of education at the Bachelor‘s degree (Bachelor of Arts, BA, or Bachelor of Science in 
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Nursing, BSN). Two of the 17 participants or 12% reported a highest educational level at the 
Associate‘s degree and 18% (3/17) had doctorate degrees. The majority or 71% of the 
respondents, were registered nurses (RN‘s, both BSN and Associate‘s degree level). Two 
participants identified as medical doctors (MD‘s, one board-certified Rheumatologist and one 
medical doctor from Mexico), and others identified as the following: one Licensed Vocational 
Nurse (LVN), one Certified Recreational Therapist (CRT), one Doctorate of Nursing Practice 
(DNP), two Masters degrees in Public Health (MPH), and two case managers (CM).  
Subspecialty certifications and areas of practice covered a broad spectrum (with several 
individuals carrying multiple roles) ranging from veterans to hospice and geriatrics, community 
HIV, Rheumatology/pain management (private MD practice), substance abuse/Methadone 
Maintenance Treatment (MMT), long-term care (LTC), business administration, case 
management, public health, inpatient nursing and community and residential mental health 
arenas and the majority (77%) worked with adults ages 18-65 or older. Almost 77% of 
individuals work full-time, 30+ hours per week, while the remaining members of the cohort 
worked either part-time or per diem, with one unemployed new graduate volunteering four hours 
weekly. Fifty-three percent identified their work settings as being comprised of upwards of 51% 
licensed nursing personnel while only 24% identified their setting as having less than 10% non-
nursing mental health professionals. The demographic data is summarized in Table IV below. 
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Participant Demographic Summary:  Table IV     
 
AGE                                                    (n=17) PERCENT       
20-30 years  6%     
31-40 years 24%   
41-50 years 18%    
51-60 years 41%    
61 + years 12%    
  
GENDER  
Female 71%    
Male 29%    
  
ETHINICITY  
Asian/Filipino 35%     
Caucasian 29%     
Latino/Hispanic 18%     
No response identified 18%     
  
HIGHEST LEVEL OF   
EDUCATION ATTAINED  
Associate degree 12%      
Bachelors degree 24%      
Masters degree 47%      
Doctorate degree 18%      
  
PROFESSIONAL ROLE  
LVN (licensed vocational nurse) 6%       
RN (registered nurse) or BSN 71%    
MD (medical degree) 12%     
MPH (masters degree public health) 12%     
Other-CRT (certified recreational therapist) 6%       
  
POPULATION CARED FOR  
Ages <18 years 12%    
Ages 18-65 years 77%     
Ages 66+ years  35%     
  
WORK STATUS  
Full-time (30+ hours/week) 77%     
Part-time (<30 hours/week) 12%      
Per diem, Unemployed/Volunteer 12%      
  
WORK SETTING STAFF MIX  
Over 50% professional nursing personnel 53% 
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 In terms of content knowledge on the pre-assessment (Evaluation A), the overall data is 
summarized in Tables V, VI, and VII below. 
Table V 
 
Evaluation A Individual Participant‘s Total Percent Correct Score on Items A-11 through A-17 
 
43% 71% 57% 29% 29% 29%  29% 43% 14% 43% 43% 43% 29% 29% 71% 71% 57% 
 
Table VI 
 
Evaluation A Total Percent Scored Correctly for each item by all participants 
 
Item A-11 
CD 
Identification 
Item A-12 
CD Types 
Item A-13 
CD 
Epidemiol
ogy 
Item A-14 
CD Response 
to 
Traditional  
Treatment      
Item A-15 
Identification 
of EBP for 
CD   
Item A-16 
CD areas of 
Dysfunction 
Item A-17 
% of CD 
with Axis II 
personality 
disorders 
Item A-18 
Efficacy of 
providing hope 
response to CD 
patient 
  
35%        
 
 
 
18%  
 
 
65% 
 
 
 
71% 
 
 
 
6%  
 
 
 
6%  
 
 
 
76% 
 
 
 
24% 
 
 
 
Table VII 
 
Evaluation A Summary of Participant Overall Results 
 
%  Participants Scoring 10-25% 
correct overall on Evaluation A 
 
6%  
 
%  Participants Scoring 26-50% 
correct overall on Evaluation A 
 
65%    
%  Participants Scoring 51-75% 
correct overall on Evaluation A 
 
29%     
%  Participants Scoring 76-100% 
correct overall on Evaluation A 
 
0%       
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Comparison of Pre-Assessment (Evaluation A) and Post-Assessment (Evaluation B) Results 
 
One particular interesting outcome on Evaluation A is the finding that the majority (11/17 
or 65%) of the cohort was unable to accurately identify the correct length of time (2 years or 
longer) required for a client to be determined chronically depressed. This data stands in contrast 
to the post-evaluation (B) after the event when 100% correctly answered this particular content 
question. Thus, this area of content appears to be clear by all the participants after the workshop 
content presentation. The majority, or 82% of participants, again incorrectly responded to the 
content regarding the recognized and Evidence-Based types of CD on the pre-assessment 
(Evaluation A).  On the post-evaluation (Evaluation B), the cohort improved and half were able 
to correctly identify CD types in a ‗select all that apply‘ format, that also captured a majority of 
correct responses along with any incorrect answers. Sixty-five and 75% respectively, answered 
correctly on the pre-test items inquiring about typical CD response to therapeutic approaches and 
the epidemiology of CD and this was similarly reflected on the post-test B for both content 
items.   
The majority of participants however, incorrectly identified effective evidence-based 
psychotherapeutic modalities for the treatment of CD in the pre-assessment. This knowledge 
improved on post-assessment B to 67% correct responses, again in a ‗select all that apply‘ 
format, indicating that had any correct response been allowed and scored, the percentage would 
have risen.  Only 6% (1/17) of the participants correctly responded to the statement regarding the 
areas of typical dysfunction for CD clients whereas 100% responded correctly on post-
assessment (Evaluation B). Participants wholeheartedly (77%) believed before the workshop that 
‗providing hope‘ to a CD patient is important message to offer in treatment. This question was 
poorly worded as the answer was intended to be false, to capture the ineffectual nature of 
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providing hope to CD clients, but it was misleading and makes it difficult to make any 
comparison or inferences on the post-assessment.  
Three post-evaluation (Evaluation B) content areas (See Tables VIII, IX and X below for 
results) looking at the primary goals of CBASP, the optimal provider skills in terms of CBASP 
and the use of positive reinforcement all scored poorly on post-evaluation perhaps indicating a 
need for more clarity in this content. Also, the nature of ‗select all that apply‘ questions that are 
scored only if answered entirely accurately, may skew the results further. Thus, it is a 
consideration for future evaluative measures, to employ a one answer option or use a different 
scoring method to improve this aspect for analysis. 
Table VIII 
 
Evaluation B Individual Participant‘s Total Percent Correct Score on Items B-1 through B-9 
 
 
67% 
 
 
67% 44% 33% 78% 89% 78% 78% 89% 56% 56% 78% 78% 67% 78% 44% 
 
 
Table IX 
 
Evaluation B Total Percent Scored Correctly for each item by all participants 
 
Item B-1 
CD 
Identifica
-tion 
Item B-2 
CD Types 
Item B-3 
CD Epi-
demiology 
Item B-4  
CD 
Response to 
Traditional  
Treatment              
Item B-5 
Identification 
of EBP for 
CD   
Item B-6 
% of CD 
with Axis 
II 
personality 
disorders 
Item B-7 
CD areas of 
Dysfunction 
Item B-8 
Skills 
needed to 
work with 
CD patients 
Item B-9 
Use of positive  
reinforcement 
in CBASP 
 
100% 
 
 
 
 
50%  
 
 
 
 
53% 
 
 
 
 
80% 
 
 
 
 
100% 
 
 
 
 
87% 
 
 
 
 
38%  
 
 
 
 
50% 
 
 
 
 
67% 
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Table X 
 
Evaluation B Summary of Participant Overall Results 
 
 
%  Participants Scoring 10-25% 
correct overall on Evaluation B 
 
0%  
 
%  Participants Scoring 26-50% 
correct overall on Evaluation B 
 
19%    
%  Participants Scoring 51-75% 
correct overall on Evaluation B 
 
31%     
%  Participants Scoring 76-100% 
correct overall on Evaluation B 
 
50%       
 
Post-Assessment (Evaluation C) Results Summary 
 
 The post-assessment, Evaluation C (See Appendix O) is a BRN and BBS requirement 
and concerns the offering of the workshop including trainer preparation, information presented 
and the facility. The most common way that participants were informed of the workshop (56%) 
was through the electronic announcement or e-flier that was sent out via email and was also 
posted in various health care venues including the Veteran‘s Administration Medical Clinics 
(VAMC), San Francisco General Hospital (SFGH), El Camino Hospital and Kaiser Permanente 
(KP) systems, and the University of California at San Francisco‘s (UCSF) Langley Porter 
Psychiatric Institute (LPPI).  The e-flier via email or posters then directed those interested to the 
website on the USF Nursing home page for further information and to register. At least two of 
the 16 respondents (12.5%) reportedly learned about the workshop directly from the website. 
Also according to Evaluation C, 59% (10/17) of participants are currently working as 
community or inpatient nurses and 35% are USF alumni and another 18% (3/17) are current USF 
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nursing students and also 18% are current USF faculty (not including the two doctoral committee 
USF faculty assistants).  
No participant stated learning of the workshop through addressed and mailed postcards; 
an interesting finding since this was the most time-consuming and expensive advertising cost and 
route.  The expense was approximately $140 including postage for an order of 150 ‗Zazzle.com‘ 
postcards designed by the trainer. Thirty of the postcards were postal-stamped, addressed and 
mailed to various healthcare and mental health facilities. Also of note, is that this was the 
advertising form that was sent out at the earliest date (in August) while the remaining post-cards 
were either hand- delivered or disseminated via nursing preceptors, instructors and managers, 
with whom the trainer has personal and professional contacts (in early September). However, at 
least 3 of 17 participants reportedly learned of the workshop through ‗word of mouth‘ or a 
professional colleague (and the assumption is that the colleagues learned of the workshop from 
the trainer who handed out the postcards for delivery. Additionally, 18% also learned of the 
workshop through a USF faculty member again perhaps either via word of mouth or from a 
postcard reminder. Thus, while the postcards generally were more time-consuming and costly to 
produce and disseminate, a scaled back effort might still be worthwhile in the future in terms of 
talking points with personal and professional connections for advertising. 
The e-fliers were sent out 2-3 weeks prior to the workshop (behind schedule) but yielded 
the best results (56% of the respondents) (See Appendix K for e-flier). Moreover, only two 
potential registrants from the over 3,000 USF alumni addressees who received the e-flier 
announcement responded to the trainer to mention that if they had been given more advanced 
notice, they would have been able and interested in attending. However, both registrants were 
living and working out of the state of California and were not necessarily the intended or target 
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audience. Nevertheless, a future consideration should be to send out the alumni e-flier mailings 
sooner with perhaps a reminder announcement 2-3 week prior to the event. Also, a separate 
announcement in the alumni E-Newsletter is another helpful reminder. This was an incidental 
and unplanned, yet fortuitous occurrence for this workshop, despite it being sent out the last 
week of registration (several registrations were received the last week prior to the workshop).   
For future projects, coordinating (with Thomas Listerman, the USF alumni email 
manager) the timing of the event to coincide a week or two after the E-Newsletter is sent out 
would be beneficial for future endeavors as well). In addition, since no participant represented 
the USF School of Education or counseling psychology programs, it would also be prudent to 
send out an alumni announcement to this group. 
The remaining items on Evaluation C are denoted by a likert scale (a psychometric scale 
used in survey research) with the following codes: 1=strongly agree, 2=somewhat agree, 
3=somewhat disagree and 4=strongly disagree; results are coded in Table XI below.   
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Table XI 
 
Qualitative Data from Evaluation C (the offering)  
 
Likert Scale: 1=strongly agree, 2=somewhat agree, 3=somewhat disagree, 4=strongly disagree 
 
Participant 
Responses 
Strongly Agree Somewhat Agree Somewhat 
Disagree 
Strongly 
Disagree 
―I enjoyed the 
workshop‖ 
 94% 6%   
―The trainer was 
well prepared.‖ 
100%    
―…Workshop 
provided necessary 
information …‖:   
 
―…to  increase 
knowledge regarding 
CD‖ 
100%    
―… and tools to 
increase more 
accurately identify 
CD patients‖ 
88% 12%   
―…to  understand 
CD treatment 
challenges‖ 
94% 6%   
―… to apply EB 
strategies for the 
therapeutic 
management of CD 
clients‖  
94% 6%   
―… for further 
resources & 
trainings re: CD‖ 
94% 6%   
―The workshop 
allowed adequate 
time for practice 
exercises.‖ 
88% 12%   
―I enjoyed the 
format (introduction, 
questions, timing, 
info., cases, practice, 
discussion.‖ 
94%  6%   
―The facilities met 
my expectations 
(room, buffet, 
reception) 
100%    
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Ninety-four percent of participants strongly agreed (and 6% or 1/17 participants 
somewhat agreed) that: a). they enjoyed the workshop, b). they enjoyed the format 
(introductions, timing, information, questions, cases, practice exercises, discussion etc), c). the 
workshop provided the necessary information to understand the CD treatment challenges, d). the 
workshop provided the necessary information to apply EB strategies for the therapeutic 
management of CD clients and, e). the workshop provided the necessary information for further 
resources and training regarding CD. The participants strongly agreed (88%) or somewhat 
agreed (the remaining 12%) that the workshop provided the necessary tools to more accurately 
identify CD clients, and that the workshop provided adequate time for practice exercises. 
One hundred percent of the attendees strongly agreed that the trainer was well prepared, 
that the workshop provided the necessary tools to increase their knowledge of what constitutes 
CD (also consistent with the learning improvement from pre to post assessment) and that the 
facility met the expectations (room, reception, buffet). Additional items asked for comments on 
what the participants considered to be most helpful about the workshop, least helpful and any 
future suggestions. The following are the list of all the comments:  
Most helpful: ―tool kit‖, ―practice sessions‖, ― introductions, simulations‖, ― trainer‘s 
knowledge and attitude‖, ―participation from the audience. good question answering‖, 
―hands on practice, theory and didactic, teacher‘s knowledge and experience‖, ―CBASP 
applications to different patient situations‖, ―examples of specific CBASP strategies‖, 
―role play‖, ―role play‖, ―Kim Cox‖, ―passion and dynamics of instructor‖, ―Tools-
CBASP-very helpful, scenarios discussed-Pt/Clinician‖, ―Everything. Learned accurately 
CD patients.‖, ―Alternative strategies to deal with CD patients‖, ―Interactive delivery‖, 
―Explanation of CBASP tools, case studies, expertise of professor‖.:  
 
 Least Helpful: ―n/a‖, ―nothing‖, ―0‖, ―writing scenarios‖. 
 
Future Suggestions: ―follow-up on future events on depression with adolescents as well‖, 
―watch video of CBASP interaction. Thanks!‖, ―Keep going!‖, ―follow-up workshop do 
simulations, lots of them-really here for them‖, ―medical/pain and depression seminar‖, 
―more role playing! More practice working the steps and tools…maybe more examples of 
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conversations highlighting the specific tools‖, ―no-excellent workshop‖, ―perfectly 
planned‖, ―having live video interventions would be great‖. 
 
Hence, the feedback was positive and all of the suggestions are reasonable and can easily be 
applied when planning future efforts. 
Two week follow-up Post-Assessment (Evaluation D) Results Summary 
 For the majority of content questions on Evaluation D (See Appendix P for Evaluation D) 
the N=12 and for a few of the application to practice setting items the N=11, as one respondent is 
not currently working and responded that these items were ―N/A‖ (hence was coded as a 0). 
Questions were assessed on a Yes/No and True/False and coded as 1 and 2 respectively (See 
Appendix ----for Table----for individual participant responses). Items were also evaluated on a 
likert scale and designated as ―Strongly agree‖ on one end of the continuum to ―Strongly 
disagree‖ on the other pole. The likert items were coded numerically for analysis from 1 to 7 
with the following descriptors assigned after receipt of responses: Strongly agree (1), moderately 
agree (2), mildly agree (3), neutral response (4), mildly disagree (5), moderately disagree (6), 
and strongly disagree (7). Other content questions queried asked respondents to select one option 
or ‗select all that apply‘. 
Item number one inquired about any changes in the provider‘s practice setting. Eighty 
three percent reported no change in their work setting, while 17% (n=2) reported a change but 
one appeared to have misinterpreted the item to imply some impact from the training.  In terms 
of CBASP application, or the respondent‘s belief that he/she was able to fully apply CBASP 
principles in the respective practice setting, 25% (3/12) strongly agreed while 6/12 mildly to 
moderately agreed so 75% of all respondents agreed to some degree that they were able to fully 
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apply CBASP principles in their practice setting. Eight percent responded neutrally while 17% (2 
out of 12) rated mild to moderate disagreement with this statement.   
Seventy-five percent of respondents strongly agreed that they found the CBASP tools kit 
easy and useful while one responded neutrally and 17% mildly to moderately disagreed. Sixty-
seven percent strongly to mildly disagreed that diagnosing CD is difficult while 25% mildly 
agreed but only one respondent strongly agreed to this statement. Incidentally, this respondent 
answered all items with a rating of 1 perhaps indicating either a misinterpretation of the question 
or a rushed response and bias. Twenty-seven percent of respondents found tools to identify CD 
clients useful and easy to apply and an additional 55% rated mild to moderate agreement with 
this statement.  Thus, a majority or 82% found the CD diagnostic tools useful and easily 
applicable. One participant responded neutrally and one mildly disagreed as to the ease and 
usefulness of the CD diagnostic tools. Only 36% or four of 11 respondents strongly agreed that 
their current practices are similar or consistent with CBASP strategies while six of 11 or 55% 
mildly to strongly disagreed to this statement (and one respondent rated a neutral response).   
Sixty four percent of participants responded that their practice setting was very open to 
the use of CBASP tools for CD while three of 11 respondents were neutral and one mildly 
disagreed.  Only 33% correctly responded to an item evaluating their ability to accurately 
diagnose CD. However, the question‘s wording may have posed some confusion perhaps 
accounting for this low accuracy response. On the other hand, 50% correctly identified all three 
items on a question with 6 possible items covering the common manifestations of CD clients 
from a CBASP perspective while 92% and 100% correctly answered content questions 
respectively covering CD epidemiology and useful CD screening tools.  
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Also, 67% and 50% respectively, correctly responded to items inquiring about a typical 
CBASP response and optimal CBASP provider stance. Notably, however for both of these items 
almost 100% chose the correct answers but also offered incorrect responses with their correct 
answers, thereby deeming an overall incorrect coded response to the question, but still 
demonstrating some competency in this content area. Importantly, 100% of respondents reported 
that if they were not currently using CBASP tools, they planned to use the workshop tools in the 
future and felt they the ability to implement these into their practice setting (see Tables XII, XIII, 
and XIV for summary of Evaluation D results).  
Table XII 
 
Evaluation D Individual Participant‘s Total Percent Correct Score on Items D-10 through D-15  
 
and Item D-17. 
 
 
67% 
 
 
67% 44% 33% 78% 89% 78% 78% 89% 56% 56% 78% 78% 67% 78% 44% 
 
 
Table XIII 
 
Evaluation D Total Percent Scored Correctly for each item by all participants 
 
 
Item D-10 
CD  
Identification  
Item D-11  
CD  
symptoms 
Item D-12  
CD  
Epidemiology 
Item D-13  
CD  
Tools      
Item D-14 
Typical 
CBASP 
Response  
Item D-15 
Optimal 
CBASP 
Provider 
Stance 
Item D-17 
Planned use 
of CBASP 
Tools 
 
33% 
 
 
 
 
50%  
 
 
 
 
92% 
 
 
 
 
100% 
 
 
 
 
67% 
 
 
 
 
50% 
 
 
 
 
100% 
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Table XIV 
 
Evaluation D Summary of Participant Overall Results 
 
 
%  Participants Scoring 10-25% 
correct overall on Evaluation D 
 
0%  
 
%  Participants Scoring 26-50% 
correct overall on Evaluation D 
 
8%    
 
%  Participants Scoring 51-75% 
correct overall on Evaluation D 
 
67%     
 
%  Participants Scoring 76-100% 
correct overall on Evaluation D 
 
25%   
 
There were several themes provided in response to what if any barriers were encountered 
in the implementation of CBASP tools in their practice settings including:  time constraints, cost 
versus productivity, budget or service cuts, patient resistance and the problems with 
collaborating with colleagues who are unfamiliar with the CBASP approaches.  The following 
are responses to inquiry regarding specific tools that respondents are currently using and had 
found useful since the workshop two weeks prior:  
―All of the tools!‖ ―Stamp‖, ―SOH‖, ―SA‖, ―interviewing techniques‖, facilitative/active 
patient role‖, ―scenarios were fantastic‖, ―confronting the issues‖, ―refocusing the client‖, 
―focus client in-the-moment‖, ―reacting honestly to client‖ (genuine response), 
―assertiveness‖, ―Personalize it.‖ 
 
Interestingly, every tool addressed in the workshop was mentioned at least one time by at least 
one participant. Thus, while not all tools may be useful or work for every provider in every 
practice setting, at least one tool has been found to be useful within a 2 week period in terms of 
application to these particular provider settings and clients.  
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  Pre and Post Assessment Comparison Results Summary 
 A comparison of the pre and post assessments in terms of the individual participant‘s 
scores (total percent correct) on all the content items is presented in Table XV below.   
Table XV 
 
Comparison of each individual participant‘s overall total (percentage correct) scores on  
 
Evaluation A, B and D.  
 
Participant  
ID# 
Total % 
Correct Eval 
A 
Pre-
Assessment 
Total % 
Correct Eval 
B 
Post-
Assessment 
Total % 
Correct Eval  
D 
2 Week Follow-up 
Assessment  
2 43% 67% 71% 
3 71% 67% 57% 
5 57% 44% 71% 
6 29% 33% N/A 
7 29% 78% 71% 
8 29% 89% 71% 
9 29% 78% 86% 
10 43% 78% 86% 
11 14% 89% 57% 
12 43% N/A N/A 
13 43% 56% 86% 
15 43% 56% N/A 
16 29% 78% N/A 
17 29% 78% 57% 
18 71% 67% 43% 
19 71% 78% 71% 
20 57% 44% N/A 
 
*Note: ID#1, 4, and 14 did not attend, no responses entered. 
 
** ―N/A‖: missing data; no response received. 
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In summary, 24% of participants consecutively scored better across each assessment (A, 
B and D) and while 77% improved overall on at least one pre to post-assessment total score. 
Notably, five participants did not follow-up with at least one or both of the post-assessments. 
Only 12% (2/17) of the participants‘ overall scores declined across the two post-assessments 
consecutively, while an additional participant‘s score declined from the pre-evaluation A to post-
evaluation B only.  Nevertheless, in all of these cases, the scores were relatively close. Generally 
speaking however, the participants‘ overall scores on content items improved across pre and 
post-test content, perhaps indicating some learning of content knowledge (See Table XVI 
below). However, without a larger cohort and more rigorous statistical analyses, no definitive 
conclusions or implications can be derived from this data. 
Table XVI 
 
Summary Comparison Table of Participants‘ Total Percent Correct Scores on Content Items  
 
across Evaluations A, B and D. 
 
 
 Evaluation A 
 
Evaluation B Evaluation D 
%  Participants Scoring 10-25% 
correct overall  
 
6%      (1/17) 0%     (0/16) 0%     (0/12) 
%  Participants Scoring 26-50% 
correct overall  
 
65%   (11/17) 19%   (3/16) 8%     (1/12) 
%  Participants Scoring 51-75% 
correct overall  
 
29%    (5/17) 31%    (5/16) 67%   (8/12) 
%  Participants Scoring 76-100% 
correct overall  
 
0%      (0/17) 50%    (8/16) 25%   (3/12) 
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Section V 
 
In terms of continuous quality improvement (CQI) this project meets all the core criteria 
including the formation of a team (doctoral committee expert advisors, student and 
administrative assistants), clear and defined aims (as aforementioned). It also encompassed an 
understanding of and provided education regarding the unique needs of the chronic depressive 
population who are ultimately served by those multi-disciplinary professional providers who 
attended the workshop. Furthermore, identifiable measures of outcomes for the successful 
accomplishment of the workshop‘s objectives were also utilized and provided (See Appendix Q 
for CQI criteria).  The implementation process further involved a collaborative, open discussion 
process regarding strategies for producing improvement and involved planning, collection and 
use of evidence-based data for the workshop development, benchmarks, implementation and 
evaluation (See Appendices E, F, M, N, O, and P for the evidence-base guidelines and the 
evaluations measures and Tables III through XIX for outcome data). 
       Section VI  
     
    Summary of Process and the Lessons Learned 
 
 The continuing education workshop entailed detailed planning and oversight for the greater 
part of six months and was overall a successful endeavor although several areas for improvement 
were highlighted. In the implementation process, from the planning stages, to marketing, to 
presentation of the content and the follow-up evaluations, several lessons were learned.  
 Specifically, the number of participants for this type of interactive format was ideal with 
one trainer, but this workshop could also be implemented with fewer or larger numbers of 
participants, depending on room space and the level of expertise of the assistants. With more 
experienced trainers this workshop could be opened to larger numbers so long as the ability to 
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provide individual and small group focus, feedback and instruction is maintained. Another 
possibility would be to offer a larger lecture portion of the training on one day or half of one day 
and then hold smaller breakout sessions with individual experienced trainers for the interactive 
case vignette and role play simulations on a second day or second half of one day. Certainly 
there is sufficient information and activities to allow an expanded offering for a two day, 
weekend training and overall feedback from participants was uniformly positive regarding the 
interactive activities and for the possibility of additional practice.  
 Moreover, in terms of the content and teaching methods, perhaps an increased focus on 
assessment and how to identify chronically depressed patients with more interactive exercises 
might be helpful. According to the evaluations and feedback, this area was one of the more 
challenging content areas. Thus, there is a capacity to allow for improvement and more 
interaction in the morning, content-heavy lecture portion of the workshop, by modifying the 
teaching in this manner to address this issue. Additional practice exercises, case vignettes and 
perhaps video examples of the application and use of CBASP interactions and tools were also 
suggested and could easily be implemented.  
 At least one participant noted he did not enjoy or find useful, the writing exercises 
(responses to case vignettes on the evaluations). Similarly, since several other participants also 
did not fill out these sections of the evaluations and rating them was perhaps tedious and did not 
yield rigorous or insightful data, perhaps using fewer or applying them in the lecture part of the 
workshop as teaching and interactive group content with review and discussion, might prove 
more interesting and helpful overall.  
 In addition to the potential evaluation changes and scoring methods aforementioned, an 
increased focus on methods to improve participants‘ correct responses on the evaluations with 
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regards to teaching content is an area for further enhancement and modification. Adding more 
interactive case exercises to the content heavy morning session may improve learning and 
content application. 
 In terms of the advertising and marketing, time and costs may be reduced by focusing on 
electronic announcements and postings as well as the alumni list-servs since these areas yielded 
the best results in terms of the number of registrants (compared to the yield from the post cards 
and the mailing time, labor and costs). Moreover, tailoring the content and tools to target 
different areas of health care and providers and in particular primary care providers, might also 
be an important future effort since a high number of individuals are seen and treated for 
depression in primary care and this would also meet another WHO initiative goal.  
 In general, however, this pilot project served as a very successful initial effort with 
minimal cost and budget, to test the feasibility and outcomes of meeting the project‘s objectives 
and to set the stage for future workshop implementation in a similarly efficient and cost-effective 
manner. 
      Dissemination Plan 
 
 Two potential descriptive manuscripts will be completed and submitted to professional 
mental health or nursing publications to further disseminate information. One article is feasible 
to describe the knowledge and information distilled and synthesized for this project from the 
complex concepts and evidence-based psychotherapy modality. A second manuscript can 
describe the implementation of the educational intervention as one possible approach to sharing 
this information and experience. Any additional opportunities or invitations to disseminate the 
seminar information will be embraced, including poster sessions, presentations, teaching 
opportunities or staff in-services. Perhaps most importantly, the experience and post-analysis 
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have provided feedback regarding future implementation and the foundation for future 
collaborative and continuing educational efforts.  
   Implications for Advanced Nursing Practice and Conclusion  
 
Chronically depressed patients all too often receive well-intentioned but inadequate care 
from primary and even specialty care settings.  Application of evidence-based psychotherapy 
strategies and in particular the synthesized CBASP tools, may reduce long term costs, improve 
care and efficacy of providers, hope and quality of life for chronically depressed patients and 
their communities. Future efforts should focus on continuing to bring this knowledge and 
distilled strategies to nurses and mental health professionals who encounter this patient 
population. In addition, perhaps tailoring events for primary care or pain management clinicians 
who frequently attend to the chronically depressed community may further impact this 
population.   
CBASP is based on a biopsychosocial model of psychopathology and health and views 
depression as stemming from faulty coping that results in a perceptual disengagement of the 
individual from the environment (McCullough, 2000). Nursing‘s biopsychosocial framework, 
focused on learning, problem-solving, skill-building, coping, strengths and symptom 
management, cognitive and behavioral treatment approaches, makes CBASP an eminently ideal 
fit for the profession.  
Considering the complexity and treatment challenges, the consequences of increased 
morbidity and mortality rates, and the associated impact on individual quality of life and greater 
public health of chronic depression, it is imperative that mental health providers and in particular 
advance practice nurses (APN‘s) that encounter depressed clients, recognize the unmet needs of 
this population and respond.  Nurses, especially those working in the community, primary care, 
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or mental health arena, are uniquely trained and in the position to effect change by correct patient 
identification and appropriate treatment or referral. By embracing and utilizing available 
assessment, problem-solving and management tools as presented in this project and educational 
intervention, nurses can more accurately identify chronically depressed patients. Understanding 
the shortcomings of conventional treatment on a chronic population and armed with the 
knowledge of evidence-based approaches, like the CBASP tools, nurses may improve patient 
care and impact this growing societal problem at the bedside and in the patient‘s environments.  
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Appendix A 
   Chronic depression and chronic subtypes defined 
 Chronic depressions differ from the more widely recognized Major Depressive Disorder  
(MDD), also sometimes referred to as Major Depressive Episode (MDE), in terms of symptom 
severity, duration and persistence. DSM-IV, MDD (or MDE) consists of symptoms of persistent 
low mood and or anhedonia (low interest) with five additional symptoms including sleep or 
appetite disturbances, concentration difficulties (or indecisiveness), low energy or fatigue, 
psychomotor retardation or psychomotor agitation (subjective perception), feelings of 
worthlessness and or inappropriate guilt, and suicidal ideation. These symptoms typically persist 
80-100% of most days for at least two weeks and represent a distinct change in the individual‘s 
usual functioning with some level of life impairment or marked distress (APA, 1994).   
In contrast with episodic or recurrent major depressive disorders, the chronic depressions 
show similar symptoms but they persist unabated for at least two years (Trivedi & Kleiber, 2001; 
Howland, 1993a; Scott, Barker, & Eccleston, 1988).  Individuals with chronic depression often 
have difficulties coping adequately with life stressors and often have a history of developmental 
trauma, repeated interpersonal difficulties, and deficient coping tools that lead to feelings of 
hopelessness and helplessness (McCullough, et al, 2003a). 
There are five chronic course patterns identified in the literature and considered 
subcategories of chronic depression. Probably the most familiar is ‗Dysthymia‘, defined as mild 
to moderate depression symptoms occurring more days than not (typically more than 50% of the 
week) for a period of two years or longer. Prevalence data for dysthymia is about 6% (APA, 
1994).  Dysthymia frequently begins in childhood or adolescence and while the symptoms 
overlap with MDD they tend to be more chronic, persisting for years but with generally less 
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severity. The onset is often insidious and patients may report feeling depressed for as far back as 
they can recall, assuming that it is a part of their personality (APA, 1994). For the latter reason, 
patients may not seek treatment and often go unrecognized.  
A lesser recognized, but commonly occurring subtype in 20-25% of patients with MDD 
is denoted as ‗Double Depression‘ (McCullough, 2000; Scott, 1988). This subtype has a course 
pattern comprised of a single or recurrent MDD episode superimposed on a dysthymic disorder 
lasting two months or more without any symptom-free period. In addition, these double 
depression patients often start out with a dysthymic disorder and progress to periods of major 
depression without ever fully gaining remission, and eventually return to their baseline 
dysthymic level.  
The third subtype is chronic major depression. Individuals with this type meet criteria for 
unipolar MDD but symptoms persist for two years or longer (McCullough, 2000).  Recurrent 
MDD is a fourth course pattern consisting of consecutive MDD episodes for two years or longer 
but without full recovery between episodes (APA 1994).  Per DSM-IV, this type is designated by 
a chronic and longitudinal course specifier; Major Depression, ―recurrent, without full 
interepisode recovery, with no dysthymic disorder‖ (APA 1994, p.382, 387-389).  Recurrent 
major depression patients may experience diminished severity of many of their symptoms, or 
partial remission, but without a two month or longer period of full recovery. The final subtype 
was identified in a national study by Keller and colleagues (1998b) as ‗double 
depression/chronic major depression‘ for patients who simultaneously meet criteria for double 
depression (dysthymia with superimposed recurrent episodic major depressions without 
remission) and subsequently progress to chronic major depression.  
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While these subtypes may seem confusing and a challenge to accurately diagnose, they 
need to be correctly differentiated from their non-chronic counterparts in order to be 
appropriately treated.  Although chronic depression research is still in its infancy, treatment is 
now being distinguished and needs to be applied. Thus, possessing a basic understanding of the 
subtypes is helpful diagnostically, to effectively discern course patterns. McCullough and 
colleagues (2003a) found that the DSM III-R and DSM–IV chronic depression subtypes had few 
demographic, psychosocial, family history, clinical or treatment response variable differences 
(McCullough et al, 1996). Therefore, it is important to view them functionally as a single, broad 
chronic depression entity distinguished from non-chronic types.  
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Appendix B  
    Literature Review Methodology  
 The clinical problem is that chronic depression is a unique disorder that differs from 
general depressive disorders and thereby applying standard depression management approaches 
are unlikely to be adequate. The evidence search was organized into several subtopics and 
narrowed to the adult population.  Articles were searched internationally through a variety of 
search engines and websites to be discussed in further detail. Google scholar, Medline, NCBI-
www.pubmed.gov, and following reference leads or ‗related links‘ on-line from original articles 
were the ideal methods for obtaining relevant and specific articles. Searches under chronic 
depression result in a rather broad arena but there is a scarcity of specific evidence with regards 
to treatment and psychotherapy in particular, so the research is narrowed by these inherent 
restraints.   
 Evaluation of the quality of the evidence utilizes the USPSTF (2002) (via the AHRQ 
website) quality of evidence tool (See Appendix C) and the Johns Hopkins Nursing Evidence- 
Based Practice Research Evidence Appraisal (Newhouse, et. al, 2005; See Appendix D). 
Quality was also evaluated based upon several other factors including date of article publication 
and authorship credentials since the search yielded an abundance of expert opinion pieces.  
Also, well-designed RCT‘s or systematic reviews were included and considered ‗good‘ (A) 
quality evidence based on the criteria outlined in Appendix B while evidence relating to chronic 
depression specifically or just depression in general was also considered in the ratings (See 
Appendix C). All articles utilized for this paper derive from rigorous peer-reviewed journals and 
resources. 
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 The initial search looked at what is chronic depression and sought to confirm how it 
differs from non-chronic depression in terms of definition, subtypes, impact and disease burden. 
Additional prevalence data, screening, treatment resistance, and disease burden of chronicity 
evidence was also evaluated. Another search focused on depression treatment in general and any 
evidence for manual-based psychotherapies. The final search delineated evidence for the 
specificity of treatment modalities for chronic depression, and any future implications and needs. 
All major search categories are critiqued and then summarized individually in the proceeding 
sections of this paper with a few added search subsections based on the data found. 
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Appendix C 
Quality of Evidence Tool: United States Preventive Services Task Force (USPSTF, 2002); 
3-point scale for the quality of overall evidence (A=good, B=fair, and C=poor): 
A. Good: Evidence includes consistent results from well-designed, well-conducted studies in 
representative populations that directly assess the effects on health outcomes. 
(For the purposes of this paper, RCT‘s or systematic reviews of RCT‘s in addition to 
criteria listed). 
B. Fair: Evidence is sufficient to determine effects on health outcomes, but the strength of 
the evidence is limited by the number, quality, or consistency of the individual studies, 
generalizability to routine practice, or indirect nature of the evidence on health outcomes. 
(For the purposes of this paper, any evidence that refers specifically to ‗chronic 
depression‘ specifically in addition to criteria listed). 
C. Poor: Evidence is insufficient to assess the effects on health outcomes because of limited 
number or power of studies, important flaws in their design or conduct, gaps in the chain 
of evidence, or lack of information on important health outcomes.  
(For the purposes of this paper, any evidence that concerns ‗depression‘ generally and 
must be generalized to chronic depression specifically).  
http://www.ahrq.gov/clinic/3rduspstf/depression/depressr.htm originally retrieved 11-18-07,  
http://www.ahrq.gov/research/mentalix.htm#Depression and  
http://e-
archive.criced.tsukuba.ac.jp/data/doc/pdf/2010/04/Practice%20of%20Health%20Sciences%28s.p
df     retrieved and updated 10-18-2010 
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Level 
                                              Appendix D 
 
Description of Evidence Level 
Level I Study design: Experimental, Randomized Controlled Trial (RCT) 
∙Subject random assignment: treatment (tx) or control group 
     -Blind: subject (s) unaware of group assignment (control versus tx) 
     -Double-blind: both subjects and investigators are unaware of group 
assignment 
     -Open: both subject and investigator are awareof group assignment  
Study design: Meta-analysis of RCT's 
∙Quantitative synthesis of data and results from multiple studies investigating 
similar  research question (s) 
∙Statistically combines results from independent studies in order to compare 
data and results. 
 
 
Level II Study design: Quasi-experimental 
∙No random assignment of subjects 
∙No control group 
∙Independent variable is manipulated 
 
 
 
Level III Study design: Non-experiment 
(Descriptive, Naturalistic, Comparative, bservational, ad Relational 
studies) 
∙Independent variable is not manipulated 
∙May use interviews, observations, focus groups to provide  
baseline information about unknown topics 
Study design: Meta-synthesis 
∙Synthesis of multiple qualitative studies‘ findings 
∙Goalis to interpret and analyze findings 
 
Level IV Expert Consensus Opnion, Clinical Practice Guidelines, Systematic Review 
∙ Nationally recognized experts base opinions on research or consensus 
panel  
∙ Evidence-based guidelines derived from research, clinical expertise, patient 
values and choice 
 
Level V 
 
 
 
Reference: 
Individual Expert Opinion, Case Studies, Literature Reviews 
∙ Non-research evidence 
∙ Recognized expert experience or personal opinion 
 
Newhouse, et. al, 2007; Newhouse, et. al, 2005a; and Newhouse, et. al, 2005b 
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Appendix E 
Practice Guidelines 
for Chronic 
Depression  
Procedure  
Rationale Evidence Citation(s) Evidence Ratings-
based on 
Appendices B & C 
guidelines 
Routinely screen all 
patients for 
depression in general 
in all primary care 
and mental health 
clinical settings.  
Screen using any  
number of 
recognized, tested 
instruments or self-
report questionnaires, 
or one to two 
significant provider-
asked screening 
questions, and or 
follow-up diagnostic 
inquiry with use of 
DSM-IV criteria. 
Case finding methods 
also possible option.  
No consensus to best 
approach but screen. 
Screening patients for 
depression assists in 
identification/recognition 
of chronic depression 
and ultimately may 
improve outcomes.  
Screening per USPSTF 
(2002) depression 
guidelines, especially in 
high risk individuals 
may lead to more 
accurate diagnosis and 
earlier treatment.  
 
 
Many depressed patients 
become chronically 
depressed. 
●Rush, et. al, (2005) 
●Michalak & Lam 
(2002) 
●Goldman, Nielson, 
& Champion (1999) 
●Pignone, et. al, 
(2002) 
●Anderson, Nutt, & 
Deakin, (2000) 
●Keller, (2003) 
                                
 
 
 
 
●Angst, (1997) 
 
 
●I-A 
●V-B 
                               
●V-B 
                             
●IV-B  
                              
●IV-B 
                             
●V-B 
 
 
 
 
 
●V-A 
 
                                  
Correctly identify 
and differentiate the 
chronically depressed 
patient from non-
chronically depressed 
patient. 
Evidence for chronic 
depression and its 
subtypes indicates that it 
is a unique disorder with 
4-5 subtypes and 
increased disease 
burden.  Proper 
identification may lead 
to more appropriate 
treatment. 
 
●McCullough, et. al, 
(2003) 
●Tranter, et. al, 
(2002) 
● Trivedi & Kleiber, 
(2001) 
●McCullough, et. al, 
(1996) 
●Howland, (1993a) 
●Howland, (1993b) 
●Katon & Sullivan 
(1990) 
●Scott, et. al (1988) 
●Scott, (1988) 
 
●III-A 
                                
●V-B 
                                        
● IV-B 
                                       
● IV-B 
                                       
●V-B 
●V-B 
●V-C 
                                
●V-B 
●V-B                                    
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Implement 
antidepressant 
pharmacotherapy in 
combination with 
CBASP 
(psychotherapy) for 
chronic depression 
patients. 
●Manual-based 
psychotherapies are 
generally considered best 
practice for depression in 
general.  
 
 
 
 
● Evidence suggests 
pharmacological 
treatment improves 
general depression 
outcomes and chronic 
depression specifically. 
  
● Evidence suggests 
pharmacological 
treatment also improves 
chronic depressions.  
 
 
 
 
 
 
 
 
●*Evidence supports the 
efficacy of CBASP in 
combination with 
medication is appropriate 
and beneficial for 
chronic depressions.  
 
●Weissman, (2007) 
● Scott, et. al, (2003) 
● Weissman & 
Markowitz (2003) 
●Crits-Cristoph 
(1992) 
●Markowitz (1994) 
 
 
● Trivedi & Kleiber, 
(2001) 
 
 
 
 
 
●All articles also 
listed below under 
next group-CBASP 
evidence* 
●Keller, et. al, 
(1998a) 
●Keller, et. al, 
(1998b) 
●Miller, et. al, (1998) 
●Rush, et. al, (1998) 
●Thase (1992) 
 
●Denton, et. al, 
(2010) 
●Blalock, et. al. 
(2008) 
●Swan & Hull, 
(2007)  
●Schatzberg, et. al, 
(2005) 
● Klein, et. al., 
(2003) 
●Kocsis, et. al, 
(2003) 
●Nemeroff, et. al, 
(2003) 
●Manber, et. al,, 
(2003) 
●Jehle & 
McCullough (2002) 
●V-A 
●I-A 
●IV-B 
                                
●III-C 
                            
●V-B 
 
 
● V-B 
 
 
 
 
 
 
 
●I-A  
                                    
                                      
●I-A  
                                                                       
●I-A 
                                
●I-A 
●I-A 
●V-C 
                                         
●I-A  
 
●I-A 
 
●V-A 
                                                  
●I-A 
                                             
●I-A 
 
●III-A 
                                
●I-A 
                                      
●I-A  
 
●V-C 
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● Keller, et. al, 
(2000) 
●Hirschfeld, et. al., 
(2002) 
 
●I-A 
 
●I-A 
Follow CBASP 
guidelines per 
provider manual, 
McCullough, 2003; 
McCullough 2000; 
Also see Appendixes 
G & H for details. 
 
Correct application of 
CBASP tools via the 
provider manual is 
necessary to support 
efficacy as studied in 
empirical studies 
reviewed above.  
 
Provider manual outlines 
application and use from 
accurate diagnosis of 
subtype of Chronic 
Depression to 
implementation of 
CBASP approach and 
maintenance treatment.  
Gap in data-no evidence 
to support how long 
patients require 
maintenance or follow-
up to retain remission. 
●Swan & Hull 
(2007)  
●McCullough (2003)  
●Jehle & 
McCullough (2002) 
●McCullough (2000) 
 
 
●McCullough (2001) 
●V-A 
                                
●V-A 
●V-C                           
 
●V-B 
 
 
●V-B 
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Appendix F 
   Detailed practice guidelines for chronic depression  
1. Screen all adults in for depression in clinical settings per: Screening for Depression in 
Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force 
(USPSTF) (2002). Settings must meet criteria outlined in these guidelines to support 
systems and accurate diagnosis. The consensus of experts maintains that screening 
has been shown to improve accurate identification of adults with depression in 
general in primary care settings and with that identification and subsequent treatment, 
clinical outcomes improve in terms of decreased morbidity. Depression screening and 
accurate identification allows for accurate assessment of client histories in order to 
delineate if their depression course might meet criteria for a chronic (prolonged 2year 
or greater) course. Expert opinion pieces and reviews articles suggest screening for 
depression across clinical settings enhances identification of potential chronic patients 
which in turn may improve outcomes. Multiple screening tools are suggested and 
there are numerous widely recognized, empirically supported tools that accurately 
identify depression in general and allow for further follow-up screening and 
identification of chronic depressions following DSM-IV-TR criteria and the evidence 
supported (and discussed in this paper) chronic subtypes (APA, 2010) (See Appendix 
A).  Note: The establishment and maintenance of a therapeutic alliance and 
appropriate treatment setting, completion of a thorough psychiatric assessment, 
evaluation of patient safety,  coordination and collaboration of the patient‘s care with 
other clinicians and disciplines, is implied to have occurred prior to these 
recommendations as per APA and other pre-existing practice guidelines (2010).  
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2. Identification of Chronic Depression and subtypes: Once a patient is screened and 
identified as having a possible depression, a further, more in depth assessment of 
symptomatology and duration or course of illness may be made. If the course of 
illness meets the duration of two years or longer per consensus and DSM-IV-TR 
(2000) criteria, then a diagnosis of chronic depression should be made (regardless of 
subtype). Current evidence does not differentiate treatment based on chronic subtype 
although one review article suggests that treatment response may not differ across 
subtypes. However, differential treatment response is an important area for future 
study along with long-term management, relapse prevention and maintenance 
therapy. Careful consideration to co-morbid diagnoses should also be made since 
evidence suggests high co-morbidities compound treatment and outcomes although 
none of the evidence or RCT‘s studied addressed the commonly co-occurring 
diagnoses, such as substance abuse and axis II personality disorders (i.e. they were 
study exclusions) except the very recent APA practice guidelines as mentioned in this 
paper (2010). Thus, the impact on management and treatment outcome cannot be 
determined at this point and these patients may need alternative approaches or 
referrals. 
3. Apply medication therapy (see medication guidelines outside scope of this paper and 
APA, 2010). Application of clinical medication guidelines (multiple additional texts 
exist to provide medication guidelines for depression treatment in general although no 
specific guidelines exist for chronic depression).  
4. Apply combination medication and CBASP—Educate patient and provide 
McCullough‘s patient manual for CBASP (2003b). Establish therapeutic alliance. 
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Follow CBASP implementation guidelines per McCullough‘s provider manual. 
Follow manual based-psychotherapy guidelines for CBASP: 1-2 sessions/week for 
16-20 weeks (See Appendices H & I). 
5. Per CBASP guidelines and APA guidelines (2010), use standardized measures to 
monitor and follow symptoms. Specific application of regular Beck Depression Inventory 
(BDI) scores to monitor the patient‘s progress and to determine if there is generalization 
of the skills learned in CBASP is recommended with the chronic patient (McCullough, 
2003, 2000). 
6. Long-term maintenance and follow-up guidelines research is needed but patients 
should be monitored at least monthly in person, by phone follow-up or on-line weekly 
logs, as well as intermittent and as needed (prn) therapy sessions and medication 
adjustments.  
7. Patient and family psycho-education and support is recommended throughout the 
process. There is no recommendation for the use of alternative treatments but little 
evidence exists to support the definitive benefits of adjunctive complementary therapies 
such as nutritional, herbal supplements and other alternative treatments. However, use 
with medical monitoring has not proven harmful in most cases and can be useful with 
patient interest and support (APA, 2010). 
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         Appendix G 
     Market Analysis  
The official CBASP providers‘ list indicates only two certified CBASP providers in the 
greater Bay Area (http://www.cbasp.org/pro.htm). Training in this modality with founder, Dr. 
James McCullough at Virginia Commonwealth University (VCU), access to the official online 
CBASP workgroup and a complete list of CBASP providers, further supports the premise that 
there is dearth of providers in this region. While CBASP providers exist, they are in scarce 
supply worldwide. An exhaustive internet search of the San Francisco and the Bay Area further 
confirms the fact that mental health practitioners in general, providing CBASP therapy services 
are minimal, with even fewer nurses employing CBASP (See below list for details). 
The American Psychiatric Association (APA) published a study (2009) describing 
projections for the future number of physicians and almost all specialties are expected to drop in 
the coming years (http://pn.psychiatryonline.org/content/44/2/local/complete-issue.pdf).  This 
same journal advertised a training session for the May 2009 APA national conference in San 
Francisco to enhance providers‘ recognition of CD and to introduce CBASP (APA, Psychiatric 
News, 2009). Thus, nurses and those in particular with mental health training, offer a valuable 
skill set and are in optimal positions to bridge these care gaps. Nurses with their widespread 
work settings and diverse positions can provide essential early referral services as well as 
treatment with CBASP.  While barriers exist for the provision of this modality, the largest 
barriers are the lack of provider knowledge and use and patient access to adequate care. Studies 
support the inadequacy of treatment and some even suggest that less than 10% of depressed 
patients receive appropriate care (Greden, 2001). Under-recognition, inaccurate identification 
and even well-intentioned providers applying insufficient treatment to the chronic population are 
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further obstacles compounding the problem. Thus, this project is an initial, yet important step, in 
bridging the care gap by enhancing identification and knowledge of an EBP treatment for CD. 
List of San Francisco Bay Area CBASP Providers 
1. Gateway Psychiatric Services, Inc (GPS) (San Francisco, CA) www.gatewaypsychiatric.com 
 
     Kimberleigh Cox MSN, CNS, NP: trained 3/07, not currently working at clinic. 
     Rochelle Frank PhD: Clinical psychologist, trained 5/09, practices part-time in SF and part-    
     time in the East Bay. 
     Peter Forster MD: Practice owner, Psychiatrist-UCSF-affiliated. 
 
2. San Francisco Bay Area Center for Cognitive Therapy (Oakland, CA) http://www.sfbacct.com 
 
     Jacqueline Persons-Director and Clinical PhD Psychologist, UC Berkeley affiliated 
     And 3-4 other clinical psychologists trained in Cognitive Behavioral Therapy but no actual     
     listing for CBASP. 
 
3. Stanford University Medical Center, (Palo Alto, CA)  http://psychiatry.stanford.edu/ 
 
     Dr. Bruce A. Arnow MD.  
     Dr. Lisa Post MD. Stanford University Medical Center, Department of Psychiatry &    
     Behavioral Sciences. Stanford, CA.     
     Dr. Eric Levander, M.P.H. Beverly Hills, CA. 
 
(Note: these are the only ―certified‖ CBASP providers listed in California per the official 
CBASP website: http://www.cbasp.org/ ) 
 
4. Patient Resources  http://www.dbsapages.org/Info/ClinicalTrialsList.html 
 
     Lists all national depression and bipolar clinical trials. Only one clinical trial of CBASP 
     currently listed. Cornell Medical Center NY, NY (as of 12/2010). 
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Appendix H 
    Characteristics of CBASP  
 
CBASP is outlined by McCullough in a structured skills manual for clinicians (2001) and 
patient manual (2003b). The therapeutic goal is to teach chronically depressed patients that their 
behavior has interpersonal consequences. Patients become motivated to change their behavior 
through learning relationship skills and problem-solving tools in therapy. Through structured 
exercises, called Situational Analysis (SA), they learn to interact differently with their personal 
environments. The chronic patient inevitably deals with the therapist as someone they are 
making up; as someone from their past or an imaginary copy of an abusive significant other. 
Initial sessions begin with taking a significant other history (SOH) to learn what ―stamps‖ were 
left on the patient by significant others (McCullough 2006, McCullough 2000). This is to 
consider the impact major players had on the patient that may continue to play a role in his or her 
thinking, life interpretations, and behavior.  
There is a proactive use of transference that teaches the patient to deal with actual 
therapist and not a symbolic person from their past. This is done through a therapeutic tool called 
Interpersonal Discrimination Exercises (IDE) and through disciplined personal involvement 
which contrasts the clinician‘s behavior and responses with the patient‘s significant others‘ 
elicited in the SOH (McCullough, 2006).   
Situational Analysis (SA), the primary tool of CBASP, is a structured, guided, clinical 
exercise designed to exacerbate psychopathology within the therapy session (McCullough, 
2000). This is done by increasing the patient‘s discomfort or negative affect in order to enhance 
the impact of the negative reinforcement, and the problem-solving tools they will learn in order 
to minimize these feelings. The consequence of not doing anything or not making changes is that 
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the patient continues to feel depressed. The learned skills and subsequent behavior change make 
the patient feel better, and subsequent learning may become easier for the chronic patient once 
they focus on this aspect. In addition to this situational learning, another goal is to redevelop the 
patient‘s ability to see the cause and effect of their behavior with the therapist and in their 
interpersonal relationships (McCullough, 2000). The SA exercise provides a vehicle to 
specifically examine how the person‘s interpretation of a particular situation affected their 
behavior and how that in turn led to an outcome that was not desirable. The approach and 
exercises are client-centered and generated, again an easy fit within the nursing perspective. 
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Appendix I 
   Implementation of CBASP  
 McCullough‘s (2001, 2000) approach to Situational Analysis (SA) includes three phases 
implemented sequentially; Elicitation, Remediation and Generalization. During the elicitation 
phase, the patient is asked to describe a specific situation within a time-limited framework. 
During remediation, there is a revision of the patient‘s interpretations and behavior in the 
situation and the focus turns to ways of changing the outcome.  The patient is asked whether or 
not any feelings or thoughts assisted or hindered in their obtaining what they wanted in the 
situation. Alternative perspectives are derived and how these differences may have impacted or 
changed the outcome is discussed. The goal is to see how thoughts during a specific scenario 
have different effects that can alter events and outcomes. In the generalization phase, skills 
learned in the focused sessions in therapy are eventually applied to reality and to greater life 
experiences, and the patient is better able to anticipate and manage future challenges 
(McCullough, 2003b, 2001, 2000).  
 Through SA repetition, the patient will begin to generalize this learning to their greater 
lives. ‗The Skills Training Manual for Diagnosing and Treating Chronic Depression‘ outlines the 
process in further detail and is a helpful resource for clinicians (McCullough, 2001). The patient 
manual is often useful prior to initiating CBASP (McCullough, 2003b).  Both manuals can be 
ordered on-line or found in many university bookstores. Beck Depression Inventory (BDI) scores 
are also recommended to better monitor and quantify the patient‘s depression levels.   
Appendix B 
U.S. Preventive Services Task Force - Strength of Overall Evidence 
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Appendix J   
Workshop Course Outline 
 
 
Course Outline
Morning Session 
8:45 AM - 9:00 AM: Self Pre-Assessment.
9:00  AM- 9:15 AM: Welcome and Introductions
9:15 AM -10:15 AM: Overview. What is Chronic Depression? Unique 
aspects and treatment challenges.  Strategies and tools for application. 
10:15-10:30 (Break)
10:30 AM -12:00 AM: Cognitive Behavioral Analysis Systems 
Psychotherapy (CBASP) Introduction, Overview & Evidence-Base.
12:00 PM - 1:00 PM  (Lunch)
Afternoon Session
1:00 PM - 2:45 PM CBASP Skills: The Strategies "Tool Kit“, Practical 
Exercises.
2:45 PM - 3:00 PM (Break)
3:00 PM - 4:30 PM Interactive discussion: Group work & simulation case 
exercises for practical application. 
4:30 PM - 5:00 PM Conclusion, Wrap-up & Post-Assessments. 
Brief two- week follow-up survey. 
 
 
The event was easily accessible on a Saturday at USF, in Cowell Hall rooms 211 and 212, 
centrally-located smart technology classrooms, on the San Francisco, California campus. The 
rooms were sufficiently spacious and the larger classroom, where the predominant teaching 
occurred, had a maximum capacity for 44 seated individuals. The registration cost was not 
prohibitive at $40 per participant (and included lunch courtesy of the campus Bon Apetit 
service), thereby enhancing the likelihood of attendance and allowing providers and 
professionals of many different educational and professional backgrounds to participate (See 
Appendix K for Workshop e-flier announcement). Tuition fees were waived for the four 
assistants who also participated in the event. 
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           Appendix K 
        School of Nursing  
          2130 Fulton Street 
          San Francisco, CA 94117-1080 
          Tel: 415 422 6681 
          Fax: 415 422 6877 
Attention Nurses, Managers, Educators, and Mental Health Providers,  
Chronic Depression Training! 
Saturday, October 2nd, 2010 (8:15 AM to 5:00 PM)  
(Register soon! Space is very limited.)  
Sponsored by the University of San Francisco, School of Nursing  
and  
Co-Sponsored by the USF School of Education, Department of Counseling Psychology, 
Marriage & Family Therapy Program 
 
Are you or your staff frustrated working with depressed clients?  
 
MEET THE CHRONIC DEPRESSION CHALLENGE!  
Chronic Depression is a difficult and often frustrating, treatment resistant disorder 
that challenges the skills of many nurses and mental health providers.  
 Join us for a one day Chronic Depression Skills Workshop. 
  
Learn real skills for real problems and earn CEU credits while learning to apply practical 
strategies to manage chronically depressed clients!  The workshop will introduce an evidence-
based approach to the management of individuals with chronic depression and will focus on 
strategies to identify clients and apply innovative, evidence-based tools, in order to more 
effectively manage these challenging clients.  
 
Target Audience: This workshop is designed for nurses (RN's) and other mental health clinicians (including social work, 
marriage and family therapy, psychiatric techs etc.) who work with or have contact with the adult chronically depressed 
population and specifically who work in the mental health, public health, and community health arenas.  
For more information and to register: (Register soon! Space is limited!) 
http://www.usfca.edu/nursing/chronic_depression_training/ 
Chronic Depression Skills Workshop Details: 
When: Saturday, October 2
nd
, 2010 (8:15 AM-5:00 PM) 
Where: Cowell Hall rooms 211, 212 University of San Francisco, School of Nursing, 2130 Fulton Street, San 
Francisco, CA 94117    
Cost: $40 (advance, lunch provided), $45 (day of event, if space available) 
CEU‟s: 8 contact hours will be awarded to nurses, (CA-BRN) and California Board of Behavioral Sciences CE‘s 
awarded to MFT, LCSW, LPCC and LEP Licenses. 
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Appendix L 
 
                                      Workshop CBASP Tools Kit 
 
 
TOOLS KIT OVERVIEW
1. Depression Screening: Variety of valid, reliable measures:
-BDI-II, HRDS-24, GDS, PHQ-9
2. Patient Assessment-Chronic Depression Identification: 
-Graphs, Timelines, Mood Monitoring-charts, journals, Structured Tools, DSM-IV-TR
3. Facilitative Provider Role
-Optimal CBASP provider qualities
-Self-Assessment (Tools): IMI, Kiesler-Circle, Transference/Counter-transference
4. Patient Assessment-CBASP Tools:
-Significant Other History (SOH), ‘Stamps’
-Situational Analysis (SA)-Coping Survey Questionnaire (CSQ)
-Identifying Cognitive Dysfunction-Maladaptive Interpretations
-Maintaining Active Patient Role
-Maintain ‘Attentional Focus’, Learning
-Assertiveness Training Exercises
-Disciplined Personal Involvement 
-Interpersonal Discrimination Exercises (IDE)
-Proactive Use of Transference
-Use of Negative Reinforcement/Patient Motivation 
5. Follow-up: (5 M’s) Mood Monitoring, Measures, Meds, Maintenance  
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      Appendix M 
  
UNIVERSITY OF SAN FRANCISCO 
 
SCHOOL OF NURSING 
 
       EVALUATION A 
 
Chronic Depression Pre-workshop Self-Assessment  
 
          ID #:______ 
 
Please tell us a little about yourself: 
 
1. Age? (check one)   
□  20-30 years 
□ 31-40 years 
□ 41-50 years 
□ 51-60 years 
□ 61-70 years 
□ 71 years +  
 
2. Gender?   
□  Male 
□  Female 
 
3. Cultural background that you most identify with:______________________________ 
 
4. Highest level of education?  
 
□  Associate degree in (list specific)________________________________________________ 
□  Bachelors degree in (list specific)________________________________________________ 
□  Masters degree in (list specific)__________________________________________________ 
□  Doctorate degree in (list specific)________________________________________________ 
  
5. Please list you‟re a) professional role, b) credentials and c) job title (eg. for Nursing: 
LVN, RN, NP, CNS, DNP, EdD, DNSc; For Social Work and other professionals: LCSW, 
LPCC, LEP, MFT, etc please list out any acronyms that may not be commonly 
recognized): 
a.)___________________________________________________________________________ 
b.)___________________________________________________________________________
c.)___________________________________________________________________________ 
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6.  Please list any specialty areas in which you work or hold certifications (eg. mental 
health, public health, community health, adults, geriatrics, couples): ___________________ 
 
______________________________________________________________________________ 
 
 
7.  Which one of following most accurately represents the setting in which you practice the 
majority of your professional time?:  
 
□ Outpatient, Community, or Clinic setting 
□ Residential, or Home Care 
□ Forensics  
□ Veterans Administration 
□ Inpatient setting 
□ Emergent or Urgent Care setting 
□ Skilled Nursing Facility 
□ Long-Term Care Facility 
□ Academic Institution 
□ Private specialty practice (specify specialty)_______________________ 
□ Other______________________________________________________  
 
8. I work in this setting____hours/week. 
 
□  Full-time (30+hrs/week) 
□  Part-time (10-29hrs/week) 
□  Other (eg. per diem____hrs/month)_________________________ 
□  Volunteer ____hrs/week 
 
9. I spend the majority of my time with which of the following client age groups? 
 
□  Children and Adolescents (ages <18) 
□  Adults (ages 18-65) 
□  Adults(ages 66+) 
 
10. My work setting is comprised of what staff mix? (select any that apply) 
 
□ 0-9% licensed nursing personel 
□ 10-25% licensed nursing personel 
□ 26-50% licensed nursing personel 
□ 51-75% licensed nursing personel 
□ 76-100% licensed nursing personel 
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□ 0-9% licensed mental health practitioners (such as LCSW, MFT, PsyD, PhD, MD etc.) 
□ 10-25% licensed mental health practitioners 
□ 26-50% licensed mental health practitioners 
□ 51-75% licensed mental health practitioners 
□ 76-100% licensed mental health practitioners 
 
Now we‟d like to explore the knowledge our workshop participants have prior to today‟s 
workshop. Please help us evaluate that aspect. 
 
11.  A client diagnosed with a chronic depression has depressive symptoms that persist for 
at least how long? 
 
□ 2 months 
□ 6 months 
□12 months 
□ 24 months 
□ 36 months 
 
12. Which are evidence-based types of chronic depression: (select all that apply) 
 
□ Major Depression 
□ Dysthymia 
□ Cyclothymia  
□ Chronic Major Depression 
□ Double Depression 
 
13. Chronic Depression affects 5% of all clients diagnosed with a depressive disorder?  
□ True 
□ False  
 
14.  Chronic Depression typically responds to therapeutic approaches that are used for 
most major depressive disorders. 
□True 
□False 
 
15. Which of the following psychotherapy modalities are effective evidence-based 
modalities for the treatment of chronic depression? (check all that apply) 
 
□ Cognitive Behavioral Therapy (CBT) 
□ Interpersonal Therapy (IPT) 
□ Psychodynamic psychotherapy 
□ Cognitive Behavioral Analysis Systems Psychotherapy (CBASP) 
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16.  Chronic depression clients typically have difficulties in what area(s) of functioning? 
(select all that apply) 
□ endocrine functioning 
□ social and interpersonal skills 
□ mathematical and calculation abilities 
□ perceived self-efficacy in the world 
□ short to long-term memory conversion 
□ empathic responses (the ability to interact with empathy) 
 
17. Chronic depression patients frequently have co-morbid Axis II personality disorders. 
□ True 
□ False 
 
18. Providing hope that “things will get better” is an important message to offer in 
treatment for the chronic depression client. 
□ True 
□ False 
 
19.  Case scenario:  “Allen”, a 45 yr old male client complains of never feeling happy since as 
far back as he can recall.  He grew up in a large family and did not receive much individual 
attention or praise as a child.  Allen was a decent student and never got into much trouble as a 
teen but has rarely succeeded or fulfilled much potential in life. Recently, his mood became 
worse after he received a job promotion. The client has been working with a psychiatrist for 
many years who has diagnosed him with chronic depression and tried numerous different 
medications to manage the depressive symptoms. Allen has experienced some relief of his 
symptoms with various med regimens but never a full recovery and has experienced numerous 
relapses despite reasonable anti-depressant management. He is otherwise healthy and has no 
current notable medical problems or lab abnormalities.   
The client reports “Ever since I got promoted I feel worse. I don‟t know but I really don‟t think I 
deserve this new position. I‟m not sure I can accept the job offer. No matter what I do, I never 
make the right decisions and I just keep feeling bad.”   
Describe (in as much space and detail as you need) how you, as the clinician (RN, SW etc), 
would next respond to this client? What would you say, ask, or do? Describe how you think 
Allen might respond to your statements, requests, questions, or actions and then add a few 
additional responses of your own. Please use next page and write legibly.      Thank you for 
your responses!
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Appendix N 
 
UNIVERSITY OF SAN FRANCISCO 
 
SCHOOL OF NURSING 
 
       EVALUATION B 
 
Chronic Depression Post-workshop Assessment    ID  #:______ 
 
1.  A client diagnosed with a chronic depression has depressive symptoms that persist for at 
least how long? 
□ 2 months 
□ 3 months 
□ 6 months 
□ one year 
□ two years 
 
2. Which of the following are evidence-based types of chronic depression: (select all that 
apply) 
□ Dysthymia  
□ Major Depression 
□ Bipolar II 
□ Double Depression 
□ Recurrent Major Depressive Disorder without full remission 
 
3. Chronic Depression affects roughly one third of all clients diagnosed with a depressive 
disorder. 
□True 
□False 
 
4.  Chronic Depression typically responds to CBT and IPT, approaches that are used for 
most major depressive disorders.   
□True 
□False 
 
5. CBASP, the only effective evidence-based psychotherapeutic modality specifically 
designed for the treatment of Chronic Depression, is based on a biopsychosocial model of 
psychopathology and health, and views depression as stemming from faulty coping that 
results in a perceptual disengagement of the individual from the environment.  
□True 
□False 
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6. Roughly half of all clients with chronic depression also meet criteria for a personality 
disorder. 
□True 
□False 
 
7. The primary goal(s) of CBASP is (are) to do which of the following (select all that apply): 
□ To correct faulty thinking errors through logical disputation. 
□ To ensure that clients learn required behaviors necessary for healthy interpersonal interactions. 
□ To teach clients to read others accurately in order to interact empathetically with them. 
□ To teach clients to feel and behave effectually in their environments. 
 
8.  Important skills needed for mental health professionals to effectively work with 
chronically depressed clients include which of the following (select all that apply):  
 
□ Ability to maintain a neutral and nonreactive demeanor with the client. 
□ Ability and comfort in taking over the responsibility when the client is emotionally or 
behaviorally stuck. 
□Ability to track moment to moment emotional reactions in oneself and the client. 
□Ability to tolerate moderate to severe negative affect in oneself and clients. 
 
9. Positive reinforcement is the strongest motivator for chronically depressed clients to 
make behavioral changes. 
□ True 
□False 
 
10. Case responses: “Brenda”, a 52 year old married woman with a long history of mood 
disturbances is recently brought in to your clinic as a new client following a recent admission to 
the local inpatient unit for suicidal ideation with intent, plan and means. She was released to 
home with this appointment and is under the supervision of a clinic psychiatrist who is 
continuing the medications that were started in the hospital. The psychiatric nurse practitioner‟s 
assessment notes a chronic depression diagnosis. Brenda‟s acute suicidality is diminished but 
her depression remains significant. She consistently criticizes herself and tells you that she feels 
“worthless” and has for many years.  
 
Describe (in as much space and detail as you need) how you, as the clinician (RN, SW etc), 
would next respond to this client? What would you say, ask, or do? Describe how you think 
Brenda might respond to your statements, requests, questions, or actions and then add a few 
additional responses of your own. Please write legibly. Thank you for your responses! 
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    Appendix O 
 
UNIVERSITY OF SAN FRANCISCO 
SCHOOL OF NURSING 
 
     PROGRAM EVALUATION 
 
CHRONIC DEPRESSION WORKSHOP 
Saturday Oct 2nd, 2010 (8:15am -5pm)      8 Contact Hours/CEU‟s awarded 
PRESENTOR: KIMBERLEIGH COX, MSN, NP, CNS, DNPc 
 
Program Objectives 
 
At the end of the workshop the participants will be able to: 
 
1. Learn to accurately identify chronic depression (CD). 
 
2. Learn evidence-based strategies to work more effectively with chronically depressed 
clients. 
 
3. Learn tools from Cognitive Behavioral Analysis Systems Psychotherapy (CBASP), a 
therapeutic modality, specifically designed for treatment of chronically depressed clients.  
 
4. Practice therapeutic strategies for the management of chronically depressed clients. 
 
5. Recognize common problems associated with the CD patient and treatment approaches. 
 
6. Identify resources for the CD patient and provider. 
 
E V A L U A T I O N  F O R M  
             
Please give us your feedback regarding the presentation. Your opinion is important 
for planning future events. Thank you for your participation! 
 
1.  How did you hear about this event? 
 
□ Electronic announcement for event 
□ USF website 
□ USF calendar of events 
□ Postcard announcement for event 
□ USF faculty member 
□ A professional colleague 
□ Word of mouth 
□ Other_____________________________________________________________________ 
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2. Are you a(n): (select all that apply) 
 
□ USF Alumnus 
□ USF Student 
□ USF Faculty member  
□ Faculty member from another school 
□ Community LVN or RN 
□ Community LCSW, MFT, LPCC, or LEP  
□ Other 
______________________________________________________________________________ 
 
Please respond to the following statements on a scale of 1-4:  
(1= strongly agree, 2= somewhat agree, 3= somewhat disagree, 4= strongly disagree). 
 
 
3. I enjoyed the workshop:  
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
4. The trainer was well prepared: 
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
5. The workshop provided necessary information to increase knowledge regarding what 
constitutes chronic depression. 
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
6. The workshop provided necessary information and tools to more accurately identify 
chronic depression clients. 
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
7. The workshop provided necessary information to understand the chronic depression 
treatment challenges.  
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
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8. The workshop provided necessary information to apply evidence-based strategies for the  
therapeutic management of chronic depression clients. 
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
9. The workshop provided necessary information for further resources and trainings 
regarding chronic depression. 
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
10. The workshop allowed adequate time for practice exercises: 
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
11. I enjoyed the format: (introductions, questions, timing, information, case studies, 
practice exercises and discussion). 
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
12. The facilities met or exceeded my expectations (room, reception, buffet). 
 
□ 1.strongly agree  □ 2. somewhat agree □ 3. somewhat disagree □ 4. strongly disagree 
 
 
13. The most helpful aspect(s) of this workshop were:________________________________ 
 
______________________________________________________________________________ 
 
 
14. The least helpful aspect(s) of this workshop were:________________________________ 
 
______________________________________________________________________________ 
 
15. Suggestions for future workshops or other comments:_____________________________ 
 
______________________________________________________________________________ 
 
 
Thank you for your feedback! 
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Appendix P 
 
UNIVERSITY OF SAN FRANCISCO 
 
SCHOOL OF NURSING 
 
       EVALUATION  D 
 
Chronic Depression Workshop: Two-week follow-up Survey  
 
          ID #:______ 
 
1. Have there been any changes to your employment situation since your attendance at the 
Chronic Depression Workshop at USF?  
□ No  □ Yes. Describe:_______________________________________________ 
________________________________________________________________ 
 
Please circle the X that most accurately represents your opinion: 
 
2. I believe I am able to fully apply the principles of CBASP in my practice setting.   
X X                X  X  X  X  X 
Strongly Agree        Strongly Disagree 
 
3. I find using the CBASP tools kit of strategies easy and useful.  
X X                X  X  X  X  X 
Strongly Agree        Strongly Disagree 
 
4.  I find diagnosing someone with Chronic Depression is difficult. 
X X                X  X  X  X  X 
Strongly Agree        Strongly Disagree 
 
5.  I find the tools to better identify Chronic Depression clients useful and easy to apply.  
X X                X  X  X  X  X 
Strongly Agree        Strongly Disagree 
 
 
6. My current practices are similar or consistent with the CBASP strategies. 
X X                X  X  X  X  X 
Strongly Agree        Strongly Disagree 
 
7. My practice setting is very open to the use of CBASP tools with chronic depression 
clients. 
X X                X  X  X  X  X 
Strongly Agree        Strongly Disagree 
 
8. What, if any, are the barriers that I have encountered in the implementation of CBASP 
tools in my practice setting? 
1.____________________________________________________________________________ 
2.____________________________________________________________________________ 
3.____________________________________________________________________________  
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9. Case: “Carl” is a 44 year old Caucasian gay male who grew up in a small conservative town 
before moving to a larger city and coming out as a gay-identified male. Carl lives with his 65 
year old partner of 10 years and they work together in a small business that his partner owns. 
Carl is somewhat estranged from his very traditional family who live in the town he grew up in, 
several hours away. The family tolerates his visits occasionally but they do not regularly seek out 
his company or accept his gay lifestyle. When Carl visits his family, his partner is not welcome 
and Carl is required to deny his lifestyle and sexual orientation. He presents to your clinic and is 
very depressed following a weekend visit to his family for a niece‟s birthday, several weeks ago 
that he attended alone. He reports that subsequent to this visit, he began getting into more 
arguments with his partner and is now fearful that if they were to break up, his partner‟s 
financial, living, and employment support might end. He wants to figure out why his depression 
and irritability are so persistent and to work on improving his “attitude”. He is willing to take 
medications and do „whatever it takes therapy-wise‟. His diagnosis is Dysthymia with a 
concurrent recent Major Depressive Episode. You understand this to be a chronic depressive 
course. When you meet Carl, he makes good eye contact, responds appropriately and thoroughly 
to your questions but soon becomes very emotional and begins tearing up while telling you about 
the reason for his visit. He states “I am so sorry. I really didn‟t want to cry. You must think I‟m 
really pathetic.” 
Describe (in as much space and detail as you need) how you, as the clinician (RN, SW etc), 
would next respond to this client? What would you say, ask, or do next? Describe how you 
think Carl might respond to your statements, requests, questions, or actions and then add a 
few additional responses of your own. Please write legibly. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-------------------------------------------------------------------------------------------------------------- 
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10. A client has a history of symptoms that meet criteria for several recurrent major 
depressive episodes. This client would meet criteria for chronic major depression, if which 
of the following circumstances is also met: 
□ The periods between the recurrent major depressive episodes meet criteria for dysthymia. 
□ The periods between the recurrent major depressive episodes are less than 2 months. 
□ The periods between the recurrent major depressive episodes are less than 6 months. 
□ The periods between the recurrent major depressive episodes are less than 12 months.  
 
11.  Common manifestations of chronically depressed clients from the CBASP perspective 
are: (Select all that apply) 
 
□ prelogical, precausal thinking 
□ the tendency to monologue  
□ a lack of perceived self-efficacy in the world 
□ the ability to engage in formal operational thinking 
□ empathic responsivity 
 
12. Chronically depressed clients are among the highest users of medical services, have 
high comorbidities and poorer treatment outcomes. 
 
□ True  
□ False 
 
13. Tools such as the symptom timelines, the Beck Depression Inventory (BDI), Coping 
Survey Questionaire (CSQ), and forms of Mood Charting, are all especially useful when 
working with chronically depressed clients. 
 
□ True  
□ False 
 
14. Which of the following represents a typical CBASP response (s) when working with an 
angry or hostile, chronically depressed client? (Select all that apply) 
□ Ignore the anger and redirect the client. 
□ Deal with the anger by gently trying to challenge the client‘s misperceptions, faulty reasoning 
and distorted conclusions. 
□ Ask the client ―Why do you want to treat me this way?‖ in order to teach the client that their 
behavior has consequences. 
□ Ask the client ―Why are you so angry and where do you think this feeling comes from?‖ 
□ Respond to the client by interpreting their anger for them ―Every dinner time, you become 
angry and perhaps this is related to your childhood and the distress in your home around meals.‖ 
□ Reflect their anger back to them. ―You seem angry. What‘s going on with you?‖ 
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15.  The optimal stance for a provider working with chronically depressed clients from the 
CBASP perspective is one that is: (select all that apply) 
 
□ Moderately Dominant-Friendly and Friendly-Submissive. 
□ Very Dominant and Very Friendly. 
□ Very Submissive and Very Friendly. 
□ A mirror to (or the opposite of) whatever the client ―pull‖ is at the time. 
□ Mildly hostile and dominant. 
□ Moderately Submissive-Hostile and Hostile-Dominant. 
 
16. Please list any specific CBASP strategies or tools, addressed at the workshop, that you 
find useful in your practice setting: 
 
______________________________________________________________________________ 
 
______________________________________________________________________________ 
 
17. If you are not yet using any of the workshop tools, do you plan to use any or do 
anticipate being able to incorporate any into your practice setting?  Yes_____  No______ 
 
You are done!  Thank you for taking the time to fill out this survey. Your answers and 
feedback are much appreciated! 
 
Please ensure that the survey is completed as fully as possible and returned as soon as possible 
and within one week if possible, in order to receive the full 8 CEU credits.  
Please either scan and email this survey back to kccox@usfca.edu or FAX: to 415-422-5618. 
Once the survey is received, you should receive confirmation with an electronic CEU 
certificate within 2 business days.  
 
 
  Chronic Depression     108 
 
 
Appendix Q 
―Continuous Quality Indicators (CQI) Definitions  
 ―Quality is defined as meeting and/or exceeding the expectations of our (health care 
consumers). 
 ―Success is achieved through meeting the needs of those we serve.‖ 
 ―Most problems are found in processes, not in people. CQI does not seek to blame, but 
rather to improve processes.‖ 
 ―Unintended variation in processes can lead to unwanted variation in outcomes, and 
therefore we seek to reduce or eliminate unwanted variation.‖ 
 ―It is possible to achieve continual improvement through small, incremental changes 
using the scientific method.‖ 
 ―Continuous improvement is most effective when it becomes a natural part of the way 
everyday work is done.‖ 
―Core Steps in Continuous Improvement‖ 
 ―Form a team that has knowledge of the system needing improvement.‖ 
 ―Define a clear aim.‖ 
 ―Understand the needs of the (population) … served by the system.‖ 
 ―Identify and define measures of success. 
 ―Brainstorm potential change strategies for producing improvement.‖ 
 ―Plan, collect, and use data for facilitating effective decision making.‖ 
 ―Apply the scientific method to test and refine changes.‖ 
Taken from the following resources: 
http://www.fpm.iastate.edu/worldclass/cqi.asp 
http://www.dss.louisiana.gov/index.cfm?md=pagebuilder&tmp=home&pid=114 
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Appendix R 
 
Participant Responses to case scenarios on Evaluations A, B and D with coded ratings from 
raters. Raters were blinded to each other‘s scoring. 
 
All of the following participant responses are rated from the provider perspective using the 
following numerical rating scale. (Note: all responses are transcribed verbatim.) 
 
Code: (See Table VII for results) 
 
1=offering support, encouragement 
2=use of therapeutic communication (reflection, clarification, active listening, empathic provider 
responses) 
3= information-seeking or inquiry 
4=challenging faulty logic or reframing irrational and distorted thinking errors for the patient 
5=interpreting for the patient, or attempts to get the patient to gain insight 
6=preaching to, shaming, predicting the future for the patient (fortune-telling), or offering false 
hope 
7 =neutral provider stance 
8=non-neutral provider stance (disciplined personal involvement) 
9=facilitative provider (allows client to do the work; avoids passive pulls) 
10=interpersonal discrimination exercise (―How would your significant other __ have reacted to 
you in this situation?‖ and contrasts with provider reaction) 
11=stays focused in the present moment  
12= proactive use of transference (deals with client in the moment around hot spots) 
13=maintains passive patient role 
14=maintains active patient role (avoids dominant take-overs and passive patient pulls) 
15=use of significant other history or stamps 
16= use of positive reinforcement 
17=use of negative reinforcement or intentionally exacerbating patient‘s discomfort in the 
moment (and enhancing cognitive dissonance) 
18=use of situational analysis (SA) - all or parts of it: (event description, patient‘s interpretations 
and behaviors, remediation of maladaptive thinking/distortions, specific learning to 
generalization) 
19=makes learning explicit and maintains patient‘s attentional focus 
20=providing psycho-education about illness, meds, symptoms etc. 
 
 
I. „Evaluation A‟ Case Scenario Participant Responses for Pre-Evaluation: 
#2A:“Allen you didn‟t receive much attention or praise as a child, you‟ve accomplished a lot 
recently, a job promotion is very significant. Is it possible your having difficulty giving yourself 
the praise or attention you deserve?” 
Ratings:      
  
 
#3A: missing data (item blank) 
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#5A:  “Acceptance, acknowledge, change. Acknowledge the issue or the indecision to take job 
and (_? illegible__). Promote dialogue and support that he get some help/counseling for his life 
changing decision and support as well decision. Discuss medication compliance and counseling. 
All client to (?__) with counselor/psychologist with referral as well.” 
Ratings: Rater 1 (R1)      ; Rater 2 (R2)      ; Rater 3 (R3)      
 
#6A: missing data (item blank) 
#7A:“Some where I would like to have him explore the “never” he uses. What is important to 
you? Is it possible?-Is it yours?  Need to explore what “feeling bad” means to him. What kind of 
music does he like? Eventually explore how does he make decisions? How did he come to make 
decisions this way?  Other feelings he has ever experienced? Am not sure how he would respond. 
Goal-communicate genuine interest in him as a person.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
#8A: “Allen why do you think you were promoted to this position? What qualities did you exhibit 
to receive this promotion. Allen might respond he doesn‟t know why. Allen, what are your duties 
and job description? Allen might respond with a job description. Allen, how many of your duties 
do you complete? Do you do anything helpful that you are not asked to do? Allen will probably 
respond yes to these questions because most likely he likes praise of appreciation. I would 
suggest Allen make a list of qualities. I would ask if he had to make decisions in his present job 
and how were they successful.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
#9A: missing data (item blank) 
#10A: “This client might benefit from talking through some of his “global thinking”. I might 
ask: „When was a time when you have made the right decision?‟ I might give him insight that 
these feelings are symptoms of his chronic depression, and that he could benefit from reframing 
his thought patterns. Since the med regimen has been ineffective in relieving his symptoms, I may 
refer him to a program such as CBASP or DBT. Without concurrent therapy with his 
pharmaceutical tx, his depressive thought patterns will persist. Allen may respond by negating 
suggestions, and finding fault in his success. I might point out that thought pattern, and ask how 
he came to that conclusion. Allen needs to begin to take an active role in changing these negative 
thought processes in order to make lasting change.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
 
#11A: “I would respond t the pt. in a calm nonjudgmental manner. I would say to him that I 
understand how he feels but thinks he has a lot of negative thoughts. He needs to stop the 
automatic negative thoughts and focus more on positive thinking and his pass success. I would 
give him tools I know such as CBT.” 
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Ratings: (R1)      ; (R2)      ; (R3)      
 
#12A: missing data (item blank) 
 
#13A:  “It must be frustrating to feel this way all the time. Would you be willing to learn how to 
adjust your thinking? Can we focus on self-appreciation? Talk about your strengths?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#15A: missing data (blank) 
 
#16A: ―What concerns about the new job do you have?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#17A: “I would ask Allen-What makes you feel that you don‟t deserve this new position? I think 
the pressure from accepting new position may make his depression worse adding increased 
anxiety because new responsibilities that come with new role. As he grow up he never receive a 
praise for his actions, maybe he needs a support and encouragement for his thoughts and 
actions. I hope that Allen would open-up and explain his thoughts. I would ask him to give me a 
particular situation to assess why he is feeling bad about certain things. May be try Shuttle 
technique. I like to think about the situation as… Growthcomfortanxiety 
                   discomfort        
You cannot solve the problem with the consciousness that created that.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#18A: “I am really excited about your promotion. Can you tell me why you think you deserve the 
promotion and why you think you cannot do the job.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
  
#19A: “Can you tell me why you don‟t think you deserve the new position?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
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#20A: “What has ever worked for you? What makes things easier for you? What are the little 
things that get you down? Who, if anyone, is helpful to you? What, if anything, helps?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
II. „Evaluation B‟ Case Scenario Participant Responses for Post-Evaluation: 
#2B: “Can we focus on your feeling of „worthless‟. What does that mean to you? Can you be 
specific and describe it to me… after clarification Can you explain the way you feel I‟ve 
responded to you here today? Is there a difference? What would be on goal for yourself?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
#3B: “Ask why she feels worthless. Find out when she felt worthy and what that felt like.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#5B: “1. Deal with now/What is making worthless/or feel positive. 2. Dialogue on positive and 
what is working…-Respond in redirecting –if goes back to worthless-understand and have her 
look at you and say it again.3. Clarify and see if anyone has made her feel positive in her life.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
 
#6B: missing data (item blank) 
 
#7B: “Would need to have CBASP formula (?much)  to group with this new approach.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#8B: “I would begin by asking client how she felt today-go from there to find opportunity to use 
SOH and Stamp tools to begin discussion on family dynamics.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#9B: “I would ask her to describe her interpretation of her worth. She might describe her feeling 
worthless. I would ask where she got that and differentiate her stamp from this current 
relationship.” 
   
Ratings: (R1)      ; (R2)      ; (R3)      
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#10B: “Who made you feel this way? Who taught you to feel this way? Pt answers with 
significant other. How would they react when you do something good? How did I react?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#11B: “I would ask her why she thinks of herself as „worthless‟. And what were the event(s) that 
happened to her which made her feel this way. I would ask about what her other significant had 
said to her and how she interprets those statements. I would ask her what she did when she feels 
„worthless‟ and what is the goal or desired outcome she wants to achieve…I would make sure 
that her answers are explicit. If not, I would keep asking until I got them, even though she is 
uncomfortable about my questions. I would let her know about how I feel about her. I would be 
supportive, tolerance, and accept who she is no matter what. Continue to engage in the 
conversation until she starts to read the environment and understand my feelings.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
 
#12B: missing data (form not handed in). 
#13B: missing data (item blank) 
#15B: missing data (item blank) 
 
#16B: ―Tell me about which was going on BEFORE your suicide attempt? What did this event 
mean to you? What did you do in this situation? How did it come out for you?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
  
 
#17B: “I would ask Brenda what makes her feel „worthless‟. I will do SI assessment. Ask her 
about compliance with meds. Tell me what happened that maked you try to kill yourself? Is there 
any other way to deal with the problem (situation, feelings, etc)? Tell me how you think you can 
deal with the situation? How do you see the outcome? What is the desired outcome?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
 
#18B: missing data (item blank) 
#19B: missing data (item blank) 
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#20B: “What does Brenda see as the current problem? She made it to this appointment-you are 
glad to see her. Since CD clients often focus on their depression, ask Brenda in what 
circumstances does she do better.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
III. „Evaluation D‟ Case Scenario Participant Responses for 2 week follow-up Post-
Evaluation: 
 
#2D:  “Why do you think you feel this way?  
How would your family have reacted to you in this situation? 
How did I react to you? 
What do you think it means that I acted differently? 
How does it apply to other situations” 
Pt: “You‟re a mental health nurse, you‟re supposed to be supportive. No one else (in my life) 
acts that way!” 
“Tell me about a specific situation-give me an example…” 
What did you say or do…What was the outcome? How would you like it to be different? What 
could you have said or done differently, based on what you‟ve learned here?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#3D: “I would ask Carl why he would think he was pathetic and how would his family rat to him 
crying. I would talk to him about his 10yr relationship and commend him for staying in such a 
committed relationship. I would ask him what kept him and his partner together for so long. 
Then I would ask why he felt he would if he broke up with his financial, living, and employment 
support would end. I would have him share about what skills/talents he adds to the business.  
 I would continually show him in my words, tone and actions that his sexuality does not 
affect how I treat him. I would have him compare my positive interactions with his family‟s.  I 
would have Carl reflect on how it feels when I accept him and happy he has been in such a 
loving relationship for 10 years.” 
 “I would maybe use SOH tool so I could help Carl identify what “stamp” these people 
have left in his life.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#5D: “I noticed that the issues at hand are making you cry.  Let‟s talk about the effect that all of 
this is having on you. Do you see me now, I‟m listening! The reality is that this is influencing you 
in the relationship of family and your partner! Do you not think that the issue surfaced on a 
recent home visit with family. Tell me what this means to so you! How would you like this 
weekend to have turned out” (Listen and say nothing for a moment or more.) 
 
Ratings: (R1)      ; (R2)      ; (R3)      
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#6D: not returned (missing/incomplete data). 
 
#7D: “What am I doing to communicate „pathetic‟? Why would I think „pathetic‟? What does 
this feel like -----a previous time? What brought you here? Most immediate?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
 
#8D: “Therapist-I‟d like to congratulate you on courage of willingness to recognize there is a 
problem and to work towards dealing with this problem. 
 Client: Thank you.” 
 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
#9D: “Honestly I would probably have tears in my eyes and have to express to the client that I 
do not think he is pathetic, that crying is allowed, and that his pain is very real and he is 
communicating it well.” 
 
RN: No, I don‟t think you are pathetic. It seems to me that you are hurting. 
Carl: I have been, for so long now, I can‟t remember… 
RN: And now you‟re here, talking about it. 
Carl: I don‟t know what else to do. I know I‟ve made mistakes… 
RN: Mistakes. 
Carl: I haven‟t treated me Partner very well. 
RN: How do you want to treat your partner? 
Carl: I think he deserves someone who‟s in a better mood, not irritable all the time. 
RN: How does he respond to your depression? 
Carl: I‟m afraid he‟s going to leave. 
RN: What would happen then? 
Carl: That would be the end of everything. 
 
I would continue to focus client on his fear of relationship ending. I would set a goal, “What is 
the one thing I want to help him achieve in our therapy,” and I could work toward that in each 
session. I would react to his statements, particularly irritability, in an honest open way so client 
could see he is having an effect on another person. I would use mood journaling to document his 
mood and reflect on his improvement.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
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#10D: “What from my body language would give you the impression I find you pathetic?” (Use 
concerned and attentive body language) 
Carl might respond: “I don‟t know.” 
“Who makes you feel that way?” 
Carl might respond about his family, their lack of concern for him/his lifestyle. 
Carl states how his father might respond. 
“How am I responding to you?” (show concern, empathy) 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#11D: 1) Elicitation Phase 
Event Description  
I would let him know that it‟s OK for him to cry and I would want him to tell me specifically 
what was the situation that makes him so upset at that particular moment.  This is to ask the 
patient to focus on one thing in this short therapy session.  The important thing is to help the 
client to change specific thoughts and behaviors.  Not everything can be changed at once, but 
developing a pattern of recognizing specific ways to change can lead to general change 
across situations. 
Interpretation 
He may struggle to speak only in factual term but I would try to collect as many facts as 
possible.  This would allow the client and to work with me later on in the worksheet.  I would 
encourage him to tell me what happened in the situation, just who said or did what and then, 
and describe clearly how the situation ended. I would ask him to give me three or four 
automatic thoughts that he experienced during the course of the specific situation.  It is 
important not to include thoughts prior to or after the situations.  This is the interpretation 
phrase of the situation.  I expect to hear that phrases like “why do I always fail?”, 
“everybody hates me”.   
Behavior 
I would ask him about what he did in the situation and what stands out as he thinks back on 
the event.  I would encourage him to be thorough.  I will also observe his behaviors, i.e. eye 
contact, tone of voice, delay in responses, body language, and what was said during the 
course of the interaction.   
Actual and Desired Outcomes 
I would ask him how the situation came out for him.  What was the actual outcome?   What 
did he want to happen in this situation.   
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Desired outcomes are limited things that he can control.  In other words, the desired 
outcome can not be something that is physically impossible.  Even more importantly, the 
desired outcome can not be something that he wanted somebody else to think, do, or feel 
even it is natural to desire other people to feel or do things.  This can be frustrated to him 
and he may even believe that he is being blamed for all that goes wrong.  This is not the case, 
however.  Instead, he will be taught to simply focus on things over which he has control so 
that things outside of his control no longer make him feel as though he has done something 
wrong. 
2)  Remediation 
During the remediation phase of CBASP, he and I will review each interpretation and 
behavior listed on the worksheet and determine whether it was helpful or hurtful with respect 
to increasing the likelihood that he would obtain his desired outcome in that situation. 
The goal is to self-correct maladaptive interpretations.  I will then review each interpretation 
for 3 qualities- “is it accurate?” “Is it grounded (or is it more global type thinking)?” and 
“Does it contribute to my getting what I want out of this situation (my desired outcome)”?  
For interpretations and behaviors that were helpful towards obtaining the desired outcome, 
time is spent discussing why it was helpful, what led him to choose an adaptive behavior, and 
what he might do to increase the likelihood that he will use this same approach in future 
situations.  For interpretations and behaviors that were hurtful towards obtaining the desired 
outcome, helpful alternative approaches are designed.  I will also emphasize the use of  
“if___, then___” statement to highlight that improved interpretation helps in obtaining 
situational goals.    
3) Generalization 
I would then teach the patient to take what is learned and transfer to his greater lifer after 
pinpointing the specific behavior in the exercise.  I would also ask him the question “How 
does what you learned here apply to other situations?” 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
 
#12D:  (not returned/missing data) 
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#13D: “C: What makes you think that I would think you are pathetic?” 
Pt” I feel bad about myself… 
C: Do you think you are pathetic?  
Pt: ------ 
C: Do you realize by your feeling pathetic, it has an effect on me? 
---- 
C: How would your partner have reacted to you? How did I react? 
C: Who taught you to be this way?” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
#15D: (not returned, missing data) 
#16D: (not returned, missing data) 
 
#17D: “C:‟ Why do you think you feel this way?‟ 
Carl: I don‟t know (pt is being passive) 
I will work with pt to try to get pt to gain some insight. Ask pt to identify a few significant other‟s 
in his life (past or present, positive and negative) 
„What it was like growing up in his family?‟ 
Important to determine the impact left by significant person on pt. Use of transference: to teach 
pt how to interact empathically with others, to master the required behavioral skills for healthy 
interpersonal interactions & relationships, conflict resolution.” 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#18D: ―I first would inform Carl that it is ok to be upset because his situation sounds very 
difficult.  I would acknowledge his feelings at being hurt by his family in having to deny a part of 
who he really is.  
I would ask Carl if he has any suicidal ideation.  If he responds that he does not have any 
suicidal ideation, I would then start asking him what he thinks would help the situation.  I would 
also want to know what he wants to get out of therapy.  I would also recommend that he receive 
medications appropriate to his condition and scheduled weekly sessions.” 
 
Ratings: (R1)      ; (R2)      ; (R3)      
 
 
#19D: “I would have the client refocus on the here and now not allow him to get distracted and 
steer the conversation in a different direction.  I would tell him that I can understand his being 
upset and that I am glad he has come to my office for help. Then I would ask him to tell me more 
about his relationship with his father?  Later I would ask about his relationship with his mother. 
Then I would ask about his relationship with his siblings.  Lastly I would ask open ended 
questions about his relationship with his partner?”      
Ratings: (R1)      ; (R2)      ; (R3)__________________________________________________      
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Table XVII 
 
Evaluation A Individual Participant Responses on Content Items A11 through A18 with Percent 
 
Summaries. 
 
Partic-
ipant 
ID# 
Item A-11 
CD 
Identific-
ation 
Item A-12 
CD Types 
Item A-13 
CD 
Epidem-
iology 
Item A-14 
CD 
Response 
to Tradit-
ional  Tx        
Item A-15 
Identific-
ation of 
EBP for 
CD   
Item A-16 
CD areas 
of 
Dysfunc-
tion 
Item A-17 
% of CD 
with Axis 
II 
personality 
disorders 
Item A-18 
Efficacy of 
providing 
hope 
response to 
CD patient 
Each 
Particip
-ant‟s 
Total % 
Correct 
Score on 
Items A-
11 
through 
A-17 
2 2 2 1 1 2 2 1 2 43% 
3 1 2 1 1 1 2 1 2 71% 
5 1 1 1 2 2 2 2 1 57% 
6 2 2 2 1 2 2 1 2 29% 
7 2 2 2 2 2 2 1 1 29% 
8 2 2 1 2 2 2 1 2 29% 
9 2 2 2 1 2 2 1 2 29% 
10 2 2 1 1 2 2 2 1 43% 
11 2 2 2 0 2 2 1 2 14% 
12 1 2 2 1 2 2 1 2 43% 
13 2 2 1 1 2 2 1 2 43% 
15 1 2 2 1 2 1 0 2 43% 
16 2 2 1 2 2 2 1 2 29% 
17 2 2 1 1 2 2 2 2 29% 
18 1 1 1 1 2 2 1 2 71% 
19 1 1 1 1 2 2 1 2 71% 
20 2 2 1 1 2 2 1 1 57% 
Total 
% 
Correct 
for 
each 
item 
35%        
 
(6/17) 
18%  
 
(3/17) 
65% 
 
(11/17) 
71% 
 
(12/17) 
6%  
 
(1/17) 
6%  
 
(1/17) 
76% 
 
(13/17) 
24% 
 
(4/17) 
 
Code: 
 
1=Correct Response  
 
2= Incorrect Response  
 
*Note: ID#1, 4, and 14 did not attend; no responses are entered. 
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Table XVIII 
 
Evaluation B Individual Participant Responses on Content Items B1 through B-9 with Percent  
 
Summaries. 
 
Partic- 
ipant  
ID# 
Item  
B-1 
CD 
Identif-
cation 
Item  
B-2 
CD 
Types 
Item  
B-3 
CD 
Epidem-
miology 
Item 
B-4  
CD 
Response 
to Tradit-
ional  Tx              
Item  
B-5 
Identific-
ation of 
EBP for 
CD   
Item  
B-6 
% of CD 
with Axis 
II person-
ality 
disorders 
Item  
B-7 
CD 
areas of 
Dysfun-
ction 
Item  
B-8 
Skills 
needed 
to wk 
with CD 
patients 
Item  
B-9 
Use of 
positive 
reinforce-
ment in 
CBASP 
Each 
Particip
-ant‟s 
Total % 
Correct 
Score 
2 1 1 1 1 1 1 2 2 2 67% 
3 1 2 2 1 1 1 1 2 1 67% 
5 1 2 2 1 1 1 2 2 2 44% 
6 1 1 0 0 1 0 2 2 0 33% 
7 1 2 1 1 1 1 2 1 1 78% 
8 1 1 1 1 1 1 1 1 2 89% 
9 1 1 2 1 1 1 1 1 2 78% 
10 1 2 1 1 1 1 2 1 1 78% 
11 1 1 1 1 1 1 1 1 2 89% 
12 0 0 0 0 0 0 0 0 0 N/A 
13 1 2 2 1 1 1 2 2 1 56% 
15 1 2 2 1 1 1 2 2 1 56% 
16 1 1 2 1 1 1 1 2 1 78% 
17 1 2 1 1 1 1 1 2 1 78% 
18 1 1 1 2 1 2 2 1 1 67% 
19 1 1 1 2 1 1 2 1 1 78% 
20 1 2 2 2 1 2 2 1 1 44% 
Total 
% 
Correct 
for 
each 
item 
100% 
 
 
(16/16) 
50%  
 
 
(8/16) 
53% 
 
 
(8 /15) 
80% 
 
 
(12/15) 
100% 
 
 
(16/16 ) 
87% 
 
 
(13/15) 
38%  
 
 
(6/16) 
50% 
 
 
(8/16) 
67% 
 
 
(10/15) 
 
Code: 
 
1=Correct Response  
 
2= Incorrect Response  
 
*Note: ID#1, 4, and 14 did not attend; no responses are entered. 
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     Table XIX 
 
Evaluation D Individual Participant Responses on Content Items D-10 through D-15 and Item 
  
D-17 with Percent Summaries. 
 
Partic- 
ipant 
ID# 
Item  
D-10 
CD 
Identif-
cation  
Item  
D-11  
CD  
symptoms 
Item  
D-12  
CD  
Epidem-
iology 
Item  
D-13  
CD  
Tools      
Item 
 D-14 
Typical 
CBASP 
Response  
Item  
D-15 
Optimal 
CBASP 
Provider 
Stance 
Item  
D-17 
Planned 
use of 
CBASP 
Tools 
Each  
Particip-
ant‟s 
Total % 
Correct  
Score 
2 1 2 1 1 1 2 1 71% 
3 1 2 1 1 2 2 1 57% 
5 2 1 1 1 2 1 1 71% 
6 0 0 0 0 0 0 0 N/A 
7 2 1 1 1 1 2 1 71% 
8 2 1 1 1 2 1 1 71% 
9 2 1 1 1 1 1 1 86% 
10 1 2 1 1 1 1 1 86% 
11 2 1 1 1 2 2 1 57% 
12 0 0 0 0 0 0 0 N/A 
13 1 2 1 1 1 1 1 86% 
15 0 0 0 0 0 0 0 N/A 
16 0 0 0 0 0 0 0 N/A 
17 2 1 1 1 1 2 0 57% 
18 2 2 2 1 1 2 1 43% 
19 2 2 1 1 1 1 1 71% 
20 0 0 0 0 0 0 0 N/A 
Total 
% 
Correct 
for 
each 
item 
33% 
 
 
(4/12) 
50%  
 
 
(6/12) 
92% 
 
 
(11/12) 
100% 
 
 
(12/12) 
67% 
 
 
(8 /12) 
50% 
 
 
(6/12) 
100% 
 
 
(11/11) 
 
Code: 
 
1=Correct 
 
2= Incorrect Response 
 
*Note: ID#1, 4, and 14 did not attend, no responses entered. 
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Figure 1 
 
MOOD DISORDERS GRAPHS 
 
Chronic Depressive Subtypes 
 
1. Recurrent Major Depressive Disorder   (rMMD) 
    
Manic level 
 
 
 
HYPOMANIC level       
 
 
Euthymia   (Never > 2mos of full recovery; No 2 mos offset or sx- free period & No dysthymia) 
 
 
 
 
 
DYSTHYMIC level 
                            
 
 
 
 
 
Major Depressive level 
         
(Sxs > 2 years, without any interepisode recovery) 
 
 
 
 
 
Derived from Handout #2-(Cox, CE Workshop Packet Oct, 2, 2010), page 2 
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Figure 2 
2. Dysthymia 
    
Manic level 
 
 
 
Hypomanic level       
 
 
 
 
Euthymia (‗Normal‘)   (Never has a full recovery for > 2mos symptom free) 
 
 
 
 
DYSTHYMIC level 
(Sxs > 2 years)                            
 
 
 
 
Major Depressive level      (Never meets MDE sxs for 2 weeks or longer). 
         
 
    
 
 
 
 
Derived from Handout #2-(Cox, CE Workshop Packet Oct, 2, 2010), page 3 
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Figure 3 
 
 3. Chronic Major Depressive Disorder   (CMD)  
 
 
 
Manic level 
 
 
 
Hypomanic level       
 
 
 
 
Euthymia (‗Normal‘) 
 
 
 
 
Dysthymic level 
 
 
 
 
 
Major Depressive level 
           (Symptoms > 2 years)    
 
    
Derived from Handout #2-(Cox, CE Workshop Packet Oct, 2, 2010), page 4 
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Figure 4 
 
 4. Double Depression (DD) 
    
Manic level 
 
 
 
Hypomanic level       
 
 
 
 
Euthymia (‗Normal‘) 
  
          (> 2 years) 
 
 
 
DYSTHYMIC level 
                            
 
 
                  >2wk 
 
Major Depressive level     
The MDE is superimposed on a pre-existing 2yr or longer Dysthymia. The major depression may 
be a single episode or recurrent episodes. May return to a dysthymic level or to a Major 
Depressive level but never has a 2 month or longer period of full recovery (symptom-free) 
during entire episode. 
 
(Dysthymia > 2 years with subsequent MDE‟s and dysthymic level 
and No 2 month period or longer of full remission) 
  
According to the DSM-IV (1994) Mood Disorders Field Trial (Keller, et al), ~26% of 349 adults 
in a current major depressive episode also met criteria for this, Double Depression.  
(McCullough, 2000). 
 
Derived from Handout #2-(Cox, CE Workshop Packet Oct, 2, 2010), page 5 
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Figure 5 
 
5. Double Depression/Chronic Major 
Depression (DD/CMD) 
 
    
Manic level 
 
 
 
Hypomanic level       
 
 
 
 
Euthymia (‗Normal‘)    Never has a full recovery during episode.  
 
 
DYSTHYMIC level 
                            
 
 
 
    
Major Depressive level      
       (Symptoms > 2 years)  (Symptoms > 2 years)  
      Meets Dysthymia  > 2 years and  Meets MDD sxs for > 2yrs 
 
 
 
Derived from Handout #2-(Cox, CE Workshop Packet Oct, 2, 2010), page 6 
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     Figure 6  
 
Major Depressive Disorder/Episode (MDD or MDE)  
 
Manic level 
 
 
 
Hypomanic level       
 
 
 
 
Euthymia (‗Normal‘) 
 
 
 
 
 
Dysthymic level 
 
 
 
 
 
Major Depressive level 
          (Symptoms > 2wks)    
 
 
 
 
 
 
Derived from Handout #2-(Cox, CE Workshop Packet Oct, 2, 2010), page 1 
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